Coty (COTY) 10-Q 10 Feb 25 2025 Q2 Quarterly report Financial data

COVER

COVER - shares	6 Months Ended
	Dec. 31, 2024	Feb. 03, 2025
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity File Number	001-35964
Entity Registrant Name	COTY INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	13-3823358
Entity Address, Address Line One	350 Fifth Avenue,
Entity Address, City or Town	New York,
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10118
City Area Code	212
Local Phone Number	389-7300
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth	false
Entity Shell Company	false
Title of 12(b) Security	Class A Common Stock, $0.01 par value
Trading Symbol	COTY
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding (in shares)		871,993,285
Amendment Flag	false
Entity Central Index Key	0001024305
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--06-30

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net revenues	$ 1,669.9	$ 1,727.6	$ 3,341.4	$ 3,369
Cost of sales	555.7	603.5	1,132.6	1,203
Gross profit	1,114.2	1,124.1	2,208.8	2,166
Selling, general and administrative expenses	797.3	833.4	1,605.3	1,600.8
Amortization expense	47.3	48.3	95.4	96.9
Restructuring costs	1.4	5.7	2.1	34.1
Operating income	268.2	236.7	506	434.2
Interest expense, net	54.4	60.1	116.2	129.9
Other expense (income), net	157.2	(80.8)	200.5	(4.2)
Income before income taxes	56.6	257.4	189.3	308.5
Provision for income taxes	26	71.4	68	112.3
Net income	30.6	186	121.3	196.2
Net income attributable to noncontrolling interests	1.6	0.5	3.7	1.6
Net income attributable to redeemable noncontrolling interests	5.3	4.6	11	12.1
Net income attributable to Coty Inc.	23.7	180.9	106.6	182.5
Amounts attributable to Coty Inc.
Net income attributable to Coty Inc.	23.7	180.9	106.6	182.5
Convertible Series B Preferred Stock dividends	(3.3)	(3.3)	(6.6)	(6.6)
Net income attributable to common stockholders	20.4	177.6	100	175.9
Net income attributable to common stockholders	$ 20.4	$ 177.6	$ 100	$ 175.9
Earnings per common share:
Earnings per common share - basic (in dollars per share)	$ 0.02	$ 0.20	$ 0.11	$ 0.20
Earnings per common share - diluted (in dollars per share)	$ 0.02	$ 0.20	$ 0.11	$ 0.20
Weighted-average common shares outstanding:
Basic (in shares)	871.4	892.8	869.6	873.6
Diluted (in shares)	875.2	922.8	875.2	883.3

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 30.6	$ 186	$ 121.3	$ 196.2
Other comprehensive income (loss):
Foreign currency translation adjustment	(282)	171.5	(161.4)	57
Net unrealized derivative gain (loss) on cash flow hedges, net of taxes of $(0.3) and $0.3, and $0.1 and $(0.4) during the three and six months ended, respectively	0.3	(1.1)	(0.5)	0.4
Pension and other post-employment benefits adjustment, net of tax of $1.3 and $(0.4), and $0.9 and $0.5 during the three and six months ended, respectively	(3.2)	0.6	(2.3)	(1.5)
Total other comprehensive (loss) income, net of tax	(284.9)	171	(164.2)	55.9
Comprehensive (loss) income	(254.3)	357	(42.9)	252.1
Comprehensive income attributable to noncontrolling interests:
Net income	1.6	0.5	3.7	1.6
Foreign currency translation adjustment	(0.2)	0	(0.2)	0
Total comprehensive income attributable to noncontrolling interests	1.4	0.5	3.5	1.6
Comprehensive income attributable to redeemable noncontrolling interests:
Net income	5.3	4.6	11	12.1
Foreign currency translation adjustment	(0.2)	0.2	(0.1)	0.1
Total comprehensive income attributable to redeemable noncontrolling interests	5.1	4.8	10.9	12.2
Comprehensive (loss) income attributable to Coty Inc.	$ (260.8)	$ 351.7	$ (57.3)	$ 238.3

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parentheticals) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Statement of Comprehensive Income [Abstract]
Net unrealized derivative gain (loss) on cash flow hedges, tax expense (benefit)	$ (0.3)	$ 0.3	$ 0.1	$ (0.4)
Pension and other post-employment benefits (losses), tax expense (benefit)	$ 1.3	$ (0.4)	$ 0.9	$ 0.5

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Current assets:
Cash and cash equivalents	$ 249.6	$ 300.8
Restricted cash	19	19.8
Trade receivables—less allowances of $27.3 and $24.3, respectively	594.3	441.6
Inventories	705.8	764.1
Prepaid expenses and other current assets	383.8	437.2
Total current assets	1,952.5	1,963.5
Property and equipment, net	673.9	718.9
Goodwill	3,816.4	3,905.7
Other intangible assets, net	3,418.4	3,565.6
Equity investments	1,056.7	1,090.6
Operating lease right-of-use assets	238.8	255.3
Deferred income taxes	475.5	490.8
Other noncurrent assets	92.1	92.1
TOTAL ASSETS	11,724.3	12,082.5
Current liabilities:
Accounts payable	1,364.6	1,405.6
Accrued expenses and other current liabilities	1,242.5	1,067.3
Short-term debt and current portion of long-term debt	14.4	3
Current operating lease liabilities	56.2	57.8
Income and other taxes payable	68.5	68.1
Total current liabilities	2,746.2	2,601.8
Long-term debt, net	3,387	3,841.8
Long-term operating lease liabilities	203.3	218.7
Pension and other post-employment benefits	267.4	275.2
Deferred income taxes	569.9	549.9
Other noncurrent liabilities	336.1	347.4
Total liabilities	7,509.9	7,834.8
COMMITMENTS AND CONTINGENCIES (See Note 17)
CONVERTIBLE SERIES B PREFERRED STOCK, $0.01 par value; 1.0 shares authorized; 0.1 issued and outstanding at December 31, 2024 and June 30, 2024	142.4	142.4
REDEEMABLE NONCONTROLLING INTERESTS	103.1	93.6
EQUITY:
Preferred Stock, $0.01 par value; 20.0 shares authorized, 1.0 issued and outstanding at December 31, 2024 and June 30, 2024	0	0
Class A Common Stock, $0.01 par value; 1,250.0 shares authorized, 966.3 and 962.1 issued and 872.0 and 867.8 outstanding at December 31, 2024 and June 30, 2024, respectively	9.6	9.6
Additional paid-in capital	11,322.9	11,308
Accumulated deficit	(4,791.9)	(4,898.5)
Accumulated other comprehensive loss	(959)	(795.1)
Treasury stock—at cost, shares: 94.3 at December 31, 2024 and June 30, 2024	(1,796.9)	(1,796.9)
Total Coty Inc. stockholders’ equity	3,784.7	3,827.1
Noncontrolling interests	184.2	184.6
Total equity	3,968.9	4,011.7
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY	$ 11,724.3	$ 12,082.5
Treasury stock, at cost, shares (in shares)	94.3	94.3

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Statement of Financial Position [Abstract]
Trade receivables, allowances	$ 27.3	$ 24.3
Convertible Series B preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Convertible Series B preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Convertible Series B preferred stock, shares issued (in shares)	100,000	100,000
Convertible Series B preferred stock, shares outstanding (in shares)	100,000	100,000
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	20,000,000	20,000,000
Preferred stock, shares issued (in shares)	1,000,000	1,000,000
Preferred stock, shares outstanding (in shares)	1,000,000	1,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,250,000,000	1,250,000,000
Common stock, shares issued (in shares)	966,300,000	962,100,000
Common stock, shares outstanding (in shares)	872,000,000	867,800,000
Treasury stock, at cost, shares (in shares)	94,300,000	94,300,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Millions, $ in Millions	Total	Total Coty Inc. Stockholders’ Equity	Preferred Stock	Common Stock Class A Common Stock	Stock to be issued	Additional Paid-in Capital	Receivable from sale of stock	(Accumulated Deficit)	Accumulated Other Comprehensive (Loss) Income	Treasury Stock	Noncontrolling Interests
Beginning balance (in shares) at Jun. 30, 2023			1
Balance, beginning of period at Jun. 30, 2023	$ 3,997.4	$ 3,811.1	$ 0	$ 9.1	$ 0	$ 10,898.6	$ 0	$ (4,987.9)	$ (662.4)	$ (1,446.3)	$ 186.3
Beginning balance (in shares) at Jun. 30, 2023				919.3
Beginning balance (in shares) at Jun. 30, 2023										66.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A Common Stock in connection with global offering, net of offering costs (in shares)				30
Issuance of Class A Common Stock in connection with global offering, net of offering costs	(5.5)	(5.5)		$ 0.3	31.5	311.2	(348.5)
Exercise of employee stock options and restricted stock units (in shares)				5.2
Exercise of employee stock options and restricted stock units				$ 0.1		(0.1)
Shares withheld for employee taxes	(0.8)	(0.8)				(0.8)
Share-based compensation expense	30.2	30.2				30.2
Equity Investment contribution for share-based compensation	0.7	0.7				0.7
Dividends Accrued - Convertible Series B Preferred Stock	(3.3)	(3.3)				(3.3)
Net income	2.7	1.6						1.6			1.1
Other comprehensive income (loss)	(115)	(115)							(115)
Adjustment of redeemable noncontrolling interests to redemption value	2.3	2.3				2.3
Ending balance (in shares) at Sep. 30, 2023			1
Ending balance at Sep. 30, 2023	3,908.7	3,721.3	$ 0	$ 9.5	31.5	11,238.8	(348.5)	(4,986.3)	(777.4)	$ (1,446.3)	187.4
Ending balance (in shares) at Sep. 30, 2023				954.5
Ending balance (in shares) at Sep. 30, 2023										66.5
Balance, beginning of period at Jun. 30, 2023	93.5
Balance, beginning of period at Jun. 30, 2023	142.4
Redeemable Noncontrolling Interests
Dividends Accrued - Convertible Series B Preferred Stock	3.3
Dividends Paid - Convertible Series B Preferred Stock	(3.3)
Net income	7.5
Other comprehensive loss (income)	(0.1)
Adjustment of redeemable noncontrolling interests to redemption value	(2.3)
Balance, end of period at Sep. 30, 2023	98.6
Balance, end of period at Sep. 30, 2023	142.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A Common Stock in connection with global offering, net of offering costs (in shares)				3
Issuance of Class A Common Stock in connection with global offering, net of offering costs	347.9	347.9			(31.5)	30.9	348.5
Reacquired Class A Common Stock for employee taxes (in shares)										0.1
Exercise of employee stock options and restricted stock units (in shares)				4.2
Exercise of employee stock options and restricted stock units	11.3	11.3		$ 0.1		11.2
Shares withheld for employee taxes	(17.3)	(17.3)				(17.3)
Share-based compensation expense	19.9	19.9				19.9
Equity Investment contribution for share-based compensation	0.6	0.6				0.6
Dividends Accrued - Convertible Series B Preferred Stock	(3.3)	(3.3)				(3.3)
Net income	181.4	180.9						180.9			0.5
Other comprehensive income (loss)	170.8	170.8							170.8
Adjustment of redeemable noncontrolling interests to redemption value	(7.3)	(7.3)				(7.3)
Ending balance (in shares) at Dec. 31, 2023			1
Ending balance at Dec. 31, 2023	4,612.7	4,424.8	$ 0	$ 9.6	$ 0	11,273.5	$ 0	(4,805.4)	(606.6)	$ (1,446.3)	187.9
Ending balance (in shares) at Dec. 31, 2023				961.7
Ending balance (in shares) at Dec. 31, 2023										66.6
Redeemable Noncontrolling Interests
Dividends Accrued - Convertible Series B Preferred Stock	3.3
Dividends Paid - Convertible Series B Preferred Stock	(3.3)
Net income	4.6
Other comprehensive loss (income)	0.2
Distribution to noncontrolling interests, net	(8.5)
Adjustment of redeemable noncontrolling interests to redemption value	7.3
Balance, end of period at Dec. 31, 2023	102.2
Balance, end of period at Dec. 31, 2023	$ 142.4
Beginning balance (in shares) at Jun. 30, 2024	1		1
Balance, beginning of period at Jun. 30, 2024	$ 4,011.7	3,827.1	$ 0	$ 9.6		11,308		(4,898.5)	(795.1)	$ (1,796.9)	184.6
Beginning balance (in shares) at Jun. 30, 2024	962.1			962.1
Beginning balance (in shares) at Jun. 30, 2024	94.3									94.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	$ 16.9	16.9				16.9
Equity Investment contribution for share-based compensation	0.4	0.4				0.4
Dividends Accrued - Convertible Series B Preferred Stock	(3.3)	(3.3)				(3.3)
Net income	85	82.9						82.9			2.1
Other comprehensive income (loss)	120.6	120.6							120.6
Adjustment of redeemable noncontrolling interests to redemption value	0.6	0.6				0.6
Ending balance (in shares) at Sep. 30, 2024			1
Ending balance at Sep. 30, 2024	4,231.9	4,045.2	$ 0	$ 9.6		11,322.6		(4,815.6)	(674.5)	$ (1,796.9)	186.7
Ending balance (in shares) at Sep. 30, 2024				962.1
Ending balance (in shares) at Sep. 30, 2024										94.3
Balance, beginning of period at Jun. 30, 2024	93.6
Balance, beginning of period at Jun. 30, 2024	142.4
Redeemable Noncontrolling Interests
Dividends Accrued - Convertible Series B Preferred Stock	3.3
Dividends Paid - Convertible Series B Preferred Stock	(3.3)
Net income	5.7
Other comprehensive loss (income)	0.1
Adjustment of redeemable noncontrolling interests to redemption value	(0.6)
Balance, end of period at Sep. 30, 2024	98.8
Balance, end of period at Sep. 30, 2024	142.4
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of employee stock options and restricted stock units (in shares)				4.2
Shares withheld for employee taxes	(12.7)	(12.7)				(12.7)
Share-based compensation expense	15.2	15.2				15.2
Equity Investment contribution for share-based compensation	0.3	0.3				0.3
Dividends Accrued - Convertible Series B Preferred Stock	(3.3)	(3.3)				(3.3)
Net income	25.3	23.7						23.7			1.6
Other comprehensive income (loss)	(284.7)	(284.5)							(284.5)		(0.2)
Distribution to noncontrolling interests, net	(3.9)										(3.9)
Adjustment of redeemable noncontrolling interests to redemption value	$ 0.8	0.8				0.8
Ending balance (in shares) at Dec. 31, 2024	1		1
Ending balance at Dec. 31, 2024	$ 3,968.9	$ 3,784.7	$ 0	$ 9.6		$ 11,322.9		$ (4,791.9)	$ (959)	$ (1,796.9)	$ 184.2
Ending balance (in shares) at Dec. 31, 2024	966.3			966.3
Ending balance (in shares) at Dec. 31, 2024	94.3									94.3
Redeemable Noncontrolling Interests
Dividends Accrued - Convertible Series B Preferred Stock	$ 3.3
Dividends Paid - Convertible Series B Preferred Stock	(3.3)
Net income	5.3
Other comprehensive loss (income)	(0.2)
Adjustment of redeemable noncontrolling interests to redemption value	(0.8)
Balance, end of period at Dec. 31, 2024	103.1
Balance, end of period at Dec. 31, 2024	$ 142.4

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 121.3	$ 196.2
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	210.2	212.2
Non-cash lease expense	32	31.3
Deferred income taxes	15.2	78.4
Provision (release) for bad debts	2.6	(0.2)
Provision for pension and other post-employment benefits	5.4	5
Share-based compensation	32.5	49.9
Losses (gains) on disposals of long-term assets, net	0.9	(0.1)
Realized and unrealized losses/(gains) from equity investments, net	33.9	(15.3)
Foreign exchange effects	6.6	18
Unrealized losses (gains) on forward repurchase contracts, net	145.4	(18.8)
Other	25.6	23.5
Change in operating assets and liabilities
Trade receivables	(187.1)	(139.6)
Inventories	38.9	81.9
Prepaid expenses and other current assets	13.7	(47.5)
Accounts payable	29.5	23.2
Accrued expenses and other current liabilities	9.6	138.7
Operating lease liabilities	(28.8)	(30.4)
Income and other taxes payable	16.3	(0.7)
Other noncurrent assets	(5.9)	(10.9)
Other noncurrent liabilities	14.1	13.3
Net cash provided by operating activities	531.9	608.1
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	(120.8)	(121.1)
Proceeds from sale of long-term assets	0	1.7
Payments for license acquisitions	(3)	0
Proceeds from contingent consideration from sale of discontinued business	15.6	0
Net cash used in investing activities	(108.2)	(119.4)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from short-term debt	10	0
Proceeds from revolving loan facilities	1,011.9	1,134
Repayments of revolving loan facilities	(943.8)	(1,347)
Proceeds from issuance of other long-term debt	0	1,284.3
Repayments of term loans and other long-term debt	(490.6)	(1,613.5)
Dividend payments on Class A Common Stock and Series B Preferred Stock	(6.7)	(6.8)
Net proceeds from issuance of Class A Common Stock	0	354.9
Net (payments of) proceeds from foreign currency contracts	(10.3)	0.4
Payments related to forward repurchase contracts, including hedge valuation adjustment	(77.8)	(24)
Refunds related to hedge valuation adjustment	61.8	0
Distributions to noncontrolling interests and redeemable noncontrolling interests	0	(8.5)
Payment of deferred financing fees	(2)	(39.5)
All other	(13.8)	(20.2)
Net cash used in financing activities	(461.3)	(285.9)
EFFECT OF EXCHANGE RATES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(14.4)	(3.1)
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH	(52)	199.7
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—Beginning of period	320.6	283.8
CASH, CASH EQUIVALENTS AND RESTRICTED CASH—End of period	268.6	483.5
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:
Cash paid during the period for interest	112.1	96.2
Net cash paid for income taxes	42.6	37.8
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Accrued capital expenditure additions	$ 67.1	$ 85.5

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	6 Months Ended
	Dec. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS	DESCRIPTION OF BUSINESS Coty Inc. and its subsidiaries (collectively, the “Company” or “Coty”) manufacture, market, sell and distribute branded beauty products, including fragrances, color cosmetics and skin & body related products throughout the world. Coty is a global beauty company with a rich entrepreneurial history and an iconic portfolio of brands. The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2025” refer to the fiscal year ending June 30, 2025. When used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. The Company’s sales generally increase during the second fiscal quarter as a result of increased demand associated with the winter holiday season. Financial performance, working capital requirements, sales, cash flows and borrowings generally experience variability during the three to six months preceding the holiday season. Product innovations, new product launches and the size and timing of orders from the Company’s customers may also result in variability.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2024. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three and six months ended December 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2025. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated. Restricted Cash Restricted cash represents funds that are not readily available for general purpose cash needs due to contractual limitations. Restricted cash is classified as a current or long-term asset based on the timing and nature of when or how the cash is expected to be used or when the restrictions are expected to lapse. As of December 31, 2024 and June 30, 2024, the Company had restricted cash of $19.0 and $19.8, respectively, included in Restricted cash in the Condensed Consolidated Balance Sheets. The Restricted cash balance as of December 31, 2024 primarily provides collateral for certain bank guarantees on rent, customs and duty accounts and also consists of collections on factored receivables that remain unremitted to the factor as of December 31, 2024. Restricted cash is included as a component of Cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows. Equity Investments The Company elected the fair value option to account for its investment in Rainbow JVCO LTD and subsidiaries (together, "Wella" or the “Wella Company”) to align with the Company’s strategy for this investment. The fair value is updated on a quarterly basis. The investment is classified within Level 3 in the fair value hierarchy because the Company estimates the fair value of the investment using a combination of the income approach, the market approach and private transactions, when applicable. Changes in the fair value of equity investment under the fair value option are recorded in Other expense (income), net within the Condensed Consolidated Statements of Operations (see Note 6—Equity Investments). Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the net realizable value of inventory, the fair value of equity investments, the assessment of goodwill, other intangible assets and long-lived assets for impairment and income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions will be reflected in the Condensed Consolidated Financial Statements in future periods. Tax Information The effective income tax rate for the three and six months ended December 31, 2024 and 2023 was 45.9% and 27.7%, respectively, and 35.9% and 36.4%, respectively. The change in the effective tax rate for the three months ended December 31, 2024, as compared with the three months ended December 31, 2023 is primarily attributable to the loss on forward repurchase contracts having a higher proportional impact in the current period, as well as the impact of fair value losses related to the investment in Wella taxed at a rate below the statutory rate of 21% in the current period. The change in the effective rate for the six months ended December 31, 2024, as compared with the six months ended December 31, 2023, is primarily due to the impact of a higher effective tax rate in the prior period related to the revaluation of the Company’s deferred tax liabilities due to a tax rate increase enacted in Switzerland resulting in an expense of $24.3. The effective tax rate of 45.9% for the three months ended December 31, 2024 was higher than the Federal statutory rate of 21% primarily due to the limitation on the deductibility of executive stock compensation and the limitation on the deductibility of interest expense as well as the impact of fair value losses related to the investment in Wella taxed at a rate below the statutory rate of 21%. The effective tax rate of 27.7% in the three months ended December 31, 2023 was higher than the Federal statutory rate of 21% primarily due to the limitation on the deductibility of executive stock compensation. The effective tax rate of 35.9% in the six months ended December 31, 2024 was higher than the statutory tax rate of 21% due to the limitation on the deductibility of executive stock compensation and the limitation on the deductibility of interest expense as well as the impact of fair value losses related to the investment in Wella taxed at a rate below the statutory rate of 21%. The effective tax rate of 36.4% in the six months ended December 31, 2023 was higher than the statutory tax rate of 21% primarily due to an expense of $24.3 in the period recognized on the revaluation of the Company's deferred tax liabilities due to a tax rate increase enacted in Switzerland. The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, including impacts of rate changes, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. As of December 31, 2024 and June 30, 2024, the gross amount of UTBs was $212.5 and $215.3, respectively. As of December 31, 2024, the total amount of UTBs that, if recognized, would impact the effective income tax rate is $178.7. As of December 31, 2024 and June 30, 2024, the liability associated with UTBs, including accrued interest and penalties, was $213.9 and $200.2, respectively, which was recorded in Income and other taxes payable and Other noncurrent liabilities in the Condensed Consolidated Balance Sheets. The total interest and penalties recorded in the Condensed Consolidated Statements of Operations related to UTBs was $0.8 and $0.7 for the three months ended December 31, 2024 and 2023, respectively, and $4.6 and $2.0 for the six months ended December 31, 2024 and 2023, respectively. The total gross accrued interest and penalties recorded in the Condensed Consolidated Balance Sheets as of December 31, 2024 and June 30, 2024 was $34.8 and $30.2, respectively. On the basis of the information available as of December 31, 2024, it is reasonably possible that a decrease of up to $29.6 in UTBs may occur within twelve months as a result of projected resolutions of global tax examinations and a potential lapse of the applicable statutes of limitations. Recent Accounting Pronouncements In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses . Additionally, in January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. The standard requires, in the notes to the financial statements, disclosure of specified information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization from each relevant expense caption. The amendments in ASU 2024-03 are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption and retrospective application are permitted, but not required. The Company plans to adopt the standard and make the additional required annual disclosures beginning in the fourth quarter of fiscal 2028 and the required interim disclosures beginning in the first quarter of fiscal 2029. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity discloses, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker ("CODM"), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. Annual disclosures are required for the Company in fiscal 2025. Interim disclosures are required for periods within fiscal years beginning in the first quarter of fiscal 2026. Retrospective application is required for all prior periods presented, and early adoption is permitted. The Company will adopt the standard and make the additional required disclosures beginning in the fourth quarter of fiscal 2025.

SEGMENT REPORTING

SEGMENT REPORTING	6 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
SEGMENT REPORTING	SEGMENT REPORTING Operating and reportable segments (referred to as “segments”) reflect the way the Company is managed and for which separate financial information is available and evaluated regularly by the Company's CODM in deciding how to allocate resources and assess performance. The Company has designated its Chief Executive Officer ("CEO") as the CODM. Certain income and shared costs and the results of corporate initiatives are managed by Corporate. Corporate primarily includes stock compensation expense, restructuring and realignment costs, costs related to acquisition, divestiture and early license termination activities, and impairments of long-lived assets, goodwill and intangibles that are not attributable to ongoing operating activities of the segments. Corporate costs are not used by the CODM to measure the underlying performance of the segments. With the exception of goodwill, the Company does not identify or monitor assets by segment. The Company does not present assets by reportable segment since various assets are shared between reportable segments. The allocation of goodwill by segment is presented in Note 7—Goodwill and Other Intangible Assets, net. Three Months Ended Six Months Ended SEGMENT DATA 2024 2023 2024 2023 Net revenues: Prestige $ 1,116.1 $ 1,122.6 $ 2,230.2 $ 2,187.3 Consumer Beauty 553.8 605.0 1,111.2 1,181.7 Total $ 1,669.9 $ 1,727.6 $ 3,341.4 $ 3,369.0 Operating income (loss): Prestige 222.3 200.6 463.8 422.2 Consumer Beauty 64.1 60.4 78.1 92.4 Corporate (18.2) (24.3) (35.9) (80.4) Total $ 268.2 $ 236.7 $ 506.0 $ 434.2 Reconciliation: Operating income 268.2 236.7 506.0 434.2 Interest expense, net 54.4 60.1 116.2 129.9 Other expense (income), net 157.2 (80.8) 200.5 (4.2) Income before income taxes $ 56.6 $ 257.4 $ 189.3 $ 308.5 During the first quarter of fiscal 2025, the Company revised the definitions of its product categories to better monitor against its long-term strategic objectives and to refine the presentation of certain multi-category brands. As a result, the Company has made certain reclassifications of its product sales among its product categories. The prior period has been recast to reflect the current period presentation. Fragrance products include a variety of perfumes and colognes offering various scents to suit individual preferences and occasions. Color Cosmetic products include lip, eye, facial and other color products including nail color. Body care and other products include shower gels, body sprays, and deodorants. Skincare products include moisturizers, serums, sun treatment, cleansers, toners and anti-aging creams designed to nourish, protect and improve the skin's appearance and health. Presented below are the percentage of net revenues associated with the Company’s product categories: Three Months Ended Six Months Ended PRODUCT CATEGORY 2024 2023 2024 2023 Fragrance 70.6 % 67.3 % 70.4 % 66.9 % Color Cosmetics 22.3 24.1 22.2 24.3 Body Care & Other 4.4 5.7 4.5 5.7 Skincare 2.7 2.9 2.9 3.1 Total 100.0 % 100.0 % 100.0 % 100.0 %

RESTRUCTURING COSTS

RESTRUCTURING COSTS	6 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING COSTS	RESTRUCTURING COSTS The Company continues to analyze our cost structure and evaluate opportunities to streamline operations through a range of smaller initiatives and other cost reduction activities to optimize operations in select businesses. Restructuring costs for the three and six months ended December 31, 2024 and 2023 are presented below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Total Restructuring Actions $ 1.4 $ 5.7 $ 2.1 $ 34.1 The liability balances were $39.9 and $42.6 at December 31, 2024 and June 30, 2024 respectively. The Company currently estimates that the total remaining accrual of $39.9 will result in cash expenditures of approximately $13.8, $19.3 and $6.8 in fiscal 2025, 2026 and thereafter, respectively.

INVENTORIES

INVENTORIES	6 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
INVENTORIES	INVENTORIES Inventories as of December 31, 2024 and June 30, 2024 are presented below: December 31, June 30, Raw materials $ 197.4 $ 201.2 Work-in-process 11.0 10.4 Finished goods 497.4 552.5 Total inventories $ 705.8 $ 764.1

EQUITY INVESTMENTS

EQUITY INVESTMENTS	6 Months Ended
	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
EQUITY INVESTMENTS	EQUITY INVESTMENTS The Company's equity investments, classified as Equity investments in the Condensed Consolidated Balance Sheets are represented by the following: December 31, June 30, Equity method investments: KKW Holdings (a) $ 3.7 $ 5.6 Equity investments at fair value: Wella (b) 1,053.0 1,085.0 Total equity investments $ 1,056.7 $ 1,090.6 (a) On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings. The Company accounts for this minority investment under the equity method, given it has the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company’s investment includes basis differences allocated to amortizable intangible assets. The Company recognized $0.9 and $0.9, respectively, during the three months ended December 31, 2024 and 2023, and $1.9 and $1.7 respectively, during the six months ended December 31, 2024 and 2023 representing its share of the investee’s net loss in Other expense (income), net within the Condensed Consolidated Statements of Operations. (b) As of December 31, 2024 and June 30, 2024, the Company's stake in Wella was 25.84%. The following table presents summarized financial information of the Company’s equity method investees for the period ending December 31, 2024. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share: Three Months Ended Six Months Ended 2024 2023 2024 2023 Summarized Statements of Operations information: Net revenues $ 737.9 $ 703.9 $ 1,393.4 $ 1,341.2 Gross profit 507.4 472.1 953.1 898.9 Operating income 109.1 79.6 147.8 124.5 Income before income taxes 51.3 24.2 48.8 17.4 Net income (loss) 19.2 74.2 (6.9) 57.5 The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended December 31, 2024. There were no internal movements to or from Level 3 and Level 1 or Level 2 for the period ended December 31, 2024. Equity investments at fair value: Balance as of June 30, 2024 $ 1,085.0 Total losses included in earnings (32.0) Balance as of December 31, 2024 $ 1,053.0 Level 3 significant unobservable inputs sensitivity The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company's investments carried at fair value as of December 31, 2024. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments. Fair value Valuation technique Unobservable Range Equity investments at fair value $ 1,053.0 Discounted cash flows Discount rate 9.50% (a) Growth rate 2.0% - 7.1% (a) Market multiple Revenue multiple 1.8x – 2.0x (b) EBITDA multiple 10.1x – 11.9x (b) (a) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement. (b) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies.

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS, NET	6 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS, NET	GOODWILL AND OTHER INTANGIBLE ASSETS, NET Goodwill Goodwill as of December 31, 2024 and June 30, 2024 is presented below: Prestige Consumer Beauty Total Gross balance at June 30, 2024 $ 6,214.6 $ 1,731.2 $ 7,945.8 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at June 30, 2024 $ 3,104.3 $ 801.4 $ 3,905.7 Changes during the period ended December 31, 2024 Foreign currency translation (70.5) (18.8) (89.3) Gross balance at December 31, 2024 $ 6,144.1 $ 1,712.4 $ 7,856.5 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at December 31, 2024 $ 3,033.8 $ 782.6 $ 3,816.4 Other Intangible Assets, net Other intangible assets, net as of December 31, 2024 and June 30, 2024 are presented below: December 31, June 30, Indefinite-lived other intangible assets $ 935.0 $ 944.6 Finite-lived other intangible assets, net 2,483.4 2,621.0 Total Other intangible assets, net $ 3,418.4 $ 3,565.6 The changes in the carrying amount of indefinite-lived other intangible assets are presented below: Trademarks Total Gross balance at June 30, 2024 $ 1,889.5 $ 1,889.5 Accumulated impairments (944.9) (944.9) Net balance at June 30, 2024 $ 944.6 $ 944.6 Changes during the period ended December 31, 2024 Foreign currency translation (9.6) (9.6) Gross balance at December 31, 2024 $ 1,879.9 $ 1,879.9 Accumulated impairments (944.9) (944.9) Net balance at December 31, 2024 $ 935.0 $ 935.0 Intangible assets subject to amortization are presented below: Cost Accumulated Amortization Accumulated Impairment Net June 30, 2024 License agreements and collaboration agreements $ 3,715.1 $ (1,422.5) $ (19.6) $ 2,273.0 Customer relationships 741.8 (527.8) (5.5) 208.5 Trademarks 311.7 (192.4) (0.5) 118.8 Product formulations and technology 83.7 (63.0) — 20.7 Total $ 4,852.3 $ (2,205.7) $ (25.6) $ 2,621.0 December 31, 2024 License agreements and collaboration agreements $ 3,656.0 $ (1,476.3) $ (19.6) $ 2,160.1 Customer relationships 731.4 (534.1) (5.5) 191.8 Trademarks 309.9 (197.5) (0.5) 111.9 Product formulations and technology 81.5 (61.9) — 19.6 Total $ 4,778.8 $ (2,269.8) $ (25.6) $ 2,483.4 Amortization expense was $47.3 and $48.3 for the three months ended December 31, 2024 and 2023, respectively and $95.4 and $96.9 for the six months ended December 31, 2024 and 2023, respectively.

LEASES

LEASES	6 Months Ended
	Dec. 31, 2024
Leases [Abstract]
LEASES	LEASES The Company leases office facilities under non-cancelable operating leases with terms generally ranging between 4 and 25 years. The Company utilizes these leased office facilities for use by its employees in countries in which the Company conducts its business. Leases are negotiated with third parties and, in some instances contain renewal, expansion and termination options. The Company also subleases certain office facilities to third parties when the Company no longer intends to utilize the space. None of the Company’s leases restricts the payment of dividends or the incurrence of debt or additional lease obligations, or contain significant purchase options. The following chart provides additional information about the Company’s operating leases: Three Months Ended Six Months Ended Lease Cost: 2024 2023 2024 2023 Operating lease cost $ 19.4 $ 18.7 $ 38.2 $ 37.8 Short-term lease cost 0.7 0.5 1.4 0.8 Variable lease cost 10.7 8.9 22.4 19.6 Sublease income (3.8) (4.5) (7.4) (8.4) Net lease cost $ 27.0 $ 23.6 $ 54.6 $ 49.8 Other information: Operating cash outflows from operating leases $ (18.1) $ (18.0) $ (34.9) $ (37.2) Right-of-use assets obtained in exchange for lease obligations $ 0.5 $ 17.7 $ 19.1 $ 32.7 Weighted-average remaining lease term - real estate 6.5 years 6.9 years Weighted-average discount rate - real estate leases 4.54 % 4.42 % Future minimum lease payments for the Company’s operating leases are as follows: Fiscal Year Ending June 30, 2025, remaining $ 35.3 2026 60.1 2027 52.6 2028 40.0 2029 34.8 Thereafter 80.3 Total future lease payments $ 303.1 Less: imputed interest (43.6) Total present value of lease liabilities $ 259.5 Current operating lease liabilities 56.2 Long-term operating lease liabilities 203.3 Total operating lease liabilities $ 259.5

DEBT

DEBT	6 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
DEBT	DEBT The Company’s debt balances consisted of the following as of December 31, 2024 and June 30, 2024, respectively: December 31, June 30, Short-term debt $ 1.5 $ — Senior Secured Notes (a) 2026 Dollar Senior Secured Notes due April 2026 350.0 650.0 2026 Euro Senior Secured Notes due April 2026 728.5 748.1 2027 Euro Senior Secured Notes due May 2027 520.4 534.3 2028 Euro Senior Secured Notes due September 2028 520.4 534.3 2029 Dollar Senior Secured Notes due January 2029 500.0 500.0 2030 Dollar Senior Secured Notes due July 2030 750.0 750.0 2018 Coty Credit Agreement Coty Revolving Credit Facility due July 2028 (b) 80.0 — Senior Unsecured Notes 2026 Euro Notes due April 2026 — 192.7 Finance lease obligations & other long term debt 8.2 4.3 Total debt 3,459.0 3,913.7 Less: Short-term debt and current portion of long-term debt (14.4) (3.0) Total Long-term debt 3,444.6 3,910.7 Less: Unamortized financing fees and discounts on long-term debt (57.6) (68.9) Total Long-term debt, net $ 3,387.0 $ 3,841.8 (a) As described further below, a covenant suspension period is in effect for each of the Senior Secured Notes, and in certain cases a collateral release, due to the achievement of investment grade ratings for such notes in September 2024. (b) The current portion of long-term debt includes swingline loans outstanding under the Company's revolving credit facility of $10.0 and $0.0 as of December 31, 2024 and June 30, 2024, respectively. Short-Term Debt The Company maintains short-term lines of credit and other short-term debt with financial institutions around the world. As of December 31, 2024, total short-term debt increased by $1.5 from nil as of June 30, 2024. In addition, the Company had undrawn letters of credit of $4.1 and $4.1, and bank guarantees of $18.2 and $18.4 as of December 31, 2024 and June 30, 2024, respectively. Long-Term Debt Recent Developments Redemption On December 6, 2024, the Company redeemed the remaining €180.3 (approximately $190.6) of the 2026 Euro Notes. Cash Tender Offer On December 10, 2024, the Company completed its previously announced cash tender offer and redeemed $300.0 of the Company's 2026 Dollar Senior Secured Notes (as defined below). Senior Secured Notes On July 26, 2023, the Company issued an aggregate principal amount of $750.0 of 6.625% senior secured notes due 2030 (“2030 Dollar Senior Secured Notes”) in a private offering. Coty received net proceeds of $740.6 in connection with the offering of the 2030 Dollar Senior Secured Notes. On September 19, 2023, the Company issued an aggregate principal amount of €500.0 million of 5.750% senior secured notes due 2028 ("2028 Euro Senior Secured Notes") in a private offering. Coty received net proceeds of €493.8 million in connection with the offering of the 2028 Euro Senior Secured Notes. On May 30, 2024, the Company issued an aggregate principal amount of €500.0 million of 4.50% senior secured notes due 2027 ("2027 Euro Senior Secured Notes" and, together with the 2026 Dollar Senior Secured Notes, 2026 Euro Senior Secured Notes, 2028 Euro Senior Secured Notes, 2029 Dollar Senior Secured Notes and 2030 Dollar Senior Secured Notes, the “Senior Secured Notes”) in a private offering. Coty received net proceeds of €493.7 million in connection with the offering of the 2027 Euro Senior Secured Notes. The Senior Secured Notes are senior secured obligations of Coty and are guaranteed on a senior secured basis by each of Coty’s wholly-owned domestic subsidiaries that guarantees Coty’s obligations under its existing senior secured credit facilities and are secured by first priority liens on the same collateral that secures Coty’s obligations under its existing senior secured credit facilities, as described above. The Senior Secured Notes and the guarantees are equal in right of payment with all of Coty’s and the guarantors’ respective existing and future senior indebtedness and are pari passu with all of Coty’s and the guarantors’ respective existing and future indebtedness that is secured by a first priority lien on the collateral, including the existing senior secured credit facilities, to the extent of the value of such collateral. Upon the respective Senior Secured Notes achieving investment grade ratings from two out of the three ratings agencies, the Senior Secured Notes provide for certain collateral release and covenant suspension provisions, as follows: • for the 2026 Dollar Senior Secured Notes and the 2026 Euro Senior Secured Notes, the guarantees and certain covenants will be released; • for the 2027 Euro Senior Secured Notes, the 2028 Euro Senior Secured Notes and the 2030 Dollar Senior Secured Notes, the collateral security, the guarantees and certain covenants will be released; and • for the 2029 Dollar Senior Secured Notes, the collateral security relating to the co-issuers and guarantors, the guarantees and certain covenants will be released; in each case subject to reinstatement if those ratings agencies withdraw their investment grade rating for the respective notes. As of September 2024, each of the Senior Secured Notes achieved an investment grade rating from two ratings agencies, and therefore, the applicable collateral release and covenant suspension periods are in effect for the respective Senior Secured Notes as described above. For prior debt issuances not disclosed above, please refer to Note 14 — Debt in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 (“Fiscal 2024 Form 10-K”). Optional Redemption Applicable Premium The indentures governing the Senior Secured Notes specify the Applicable Premium (as defined in the respective indentures) to be paid upon early redemption of some or all of the Senior Secured Notes prior to, and on or after, April 15, 2023 for the 2026 Euro Senior Secured Notes and 2026 Dollar Senior Secured Notes, September 15, 2025 for the 2028 Euro Senior Secured Notes, May 15, 2026 for the 2027 Euro Senior Secured Notes, January 15, 2025 for the 2029 Dollar Senior Secured Notes and July 15, 2026 for the 2030 Dollar Senior Secured Notes (the "Early Redemption Dates"). The Applicable Premium related to the respective Senior Secured Notes on any redemption date and as calculated by the Company is the greater of: (1) 1.0% of the then outstanding principal amount of the respective Senior Secured Notes; and (2) the excess, if any, of (a) the present value at such redemption date of (i) the redemption price of such respective Senior Secured Notes that would apply if such respective notes were redeemed on the respective Early Redemption Dates, (such redemption price is expressed as a percentage of the principal amount being set forth in the table appearing in the Redemption Pricing section below), plus (ii) all remaining scheduled payments of interest due on the respective Senior Secured Notes to and including the respective Early Redemption Dates, (excluding accrued but unpaid interest, if any, to, but excluding, the redemption date), with respect to each of subclause (i) and (ii), computed using a discount rate equal to the Treasury Rate in the case of the 2026 Dollar Senior Secured Notes, 2029 Dollar Senior Secured Notes and 2030 Dollar Senior Secured Notes, or Bund Rate in the case of the 2026 Euro Senior Secured Notes and the 2028 Euro Senior Secured Notes (both Treasury Rate and Bund Rate as defined in the respective indentures) as of such redemption date plus 50 basis points; over (b) the principal amount of the respective Senior Secured Notes. Redemption Pricing At any time and from time to time prior to the Early Redemption Dates, the Company may redeem some or all of the respective notes at redemption prices equal to 100% of the respective principal amounts being redeemed plus the Applicable Premium, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates. At any time on or after the Early Redemption Dates, the Company may redeem some or all of the respective notes at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on respective dates of each of the years indicated below: Price For the period beginning 2026 Dollar Senior Secured Notes 2026 Euro Senior Secured Notes 2027 Euro Senior Secured Notes 2028 Euro Senior Secured Notes 2029 Dollar Senior Secured Notes 2030 Dollar Senior Secured Notes Year April 15, May 15, November 15, September 15 January 15, July 15, 2025 100.000% 100.000% N/A N/A 102.875% 102.375% N/A 2026 N/A N/A 102.250% 100.000% 101.438% 101.188% 103.313% 2027 N/A N/A 100.000% N/A 100.000% 100.000% 101.656% 2028 and thereafter N/A N/A N/A N/A 100.000% 100.000% 100.000% 2018 Coty Credit Agreement On April 5, 2018, the Company entered into an amended and restated credit agreement (the "2018 Coty Credit Agreement"), which, as previously disclosed, was amended most recently in July 2023. As amended and restated through July 2023, the 2018 Coty Credit Agreement provides for (a) the incurrence by the Company of (1) a senior secured term A facility in an aggregate principal amount of (i) $1,000.0 denominated in U.S. dollars and (ii) €2,035.0 million denominated in euros (the “2018 Coty Term A Facility”) and (2) a senior secured term B facility in an aggregate principal amount of (i) $1,400.0 denominated in U.S. dollars and (ii) €850.0 million denominated in euros (the “2018 Coty Term B Facility”) and (b) the incurrence by the Company and Coty B.V., a Dutch subsidiary of the Company (the “Dutch Borrower” and, together with the Company, the “Borrowers”), of two tranches of senior secured revolving credit commitments, one in an aggregate principal amount of $1,670.0 available in U.S. dollars and certain other currencies and the other in an aggregate principal amount of €300.0 million available in euros, maturing in July 2028 (together, the "Coty Revolving Credit Facility" (and together with the 2018 Coty Term A Facility and the 2018 Coty Term B Facility, the "Coty Credit Facilities"). The July 2023 amendment also (i) provided for a credit spread adjustment of 0.10% for all interest periods, with respect to Secured Overnight Financing Rate ("SOFR") loans, (ii) added Fitch as a relevant rating agency for purposes of the collateral release provisions and determining applicable interest rates and fees and (iii) provided that certain covenants will cease to apply during a collateral release period. As previously disclosed, the Company has repaid all outstanding balances under the 2018 Coty Term A Facility and 2018 Coty Term B Facility and no amounts are outstanding as of September 30, 2024. The 2018 Coty Credit Agreement, as amended, provides that with respect to the Coty Revolving Credit Facility, up to $150.0 is available for letters of credit and up to $150.0 is available for swing line loans. The 2018 Coty Credit Agreement, as amended, also permits, subject to certain terms and conditions, the incurrence of incremental facilities thereunder in an aggregate amount of (i) $1,700.0 plus (ii) an unlimited amount if the First Lien Net Leverage Ratio (as defined in the 2018 Coty Credit Agreement, as amended), at the time of incurrence of such incremental facilities and after giving effect thereto on a pro forma basis, is less than or equal to 3.00 to 1.00. The obligations of the Company under the 2018 Coty Credit Agreement, as amended, are guaranteed by the material wholly-owned subsidiaries of the Company organized in the U.S., subject to certain exceptions (the “Guarantors”) and the obligations of the Company and the Guarantors under the 2018 Coty Credit Agreement, as amended, are secured by a perfected first priority lien (subject to permitted liens) on substantially all of the assets of the Company and the Guarantors, subject to certain exceptions. The Dutch Borrower does not guarantee the obligations of the Company under the 2018 Coty Credit Agreement or grant any liens on its assets to secure any obligations under the 2018 Coty Credit Agreement. The collateral security and certain covenants will be released upon the Company achieving investment grade ratings on its corporate rating from two out of the three ratings agencies, subject to certain additional conditions and subject to reversion if those ratings agencies withdraw their investment grade rating. Senior Unsecured Notes On April 5, 2018 the Company issued, at par, $550.0 of 6.50% senior unsecured notes due 2026 (the “2026 Dollar Notes”), €550.0 million of 4.00% senior unsecured notes due 2023 (the “2023 Euro Notes”) and €250.0 million of 4.75% senior unsecured notes due 2026 (the “2026 Euro Notes” and, together with the 2023 Euro Notes, the “Euro Notes,” and the Euro Notes together with the 2026 Dollar Notes, the “Senior Unsecured Notes”) in a private offering. On December 7, 2023, the Company redeemed $150.0 of the 2026 Dollar Notes, and on May 30, 2024, the Company redeemed the remaining $323.0 of the 2026 Dollar Notes. On December 6, 2024, the Company redeemed the remaining €180.3 (approximately $190.6) of the 2026 Euro Notes. Deferred Financing Costs The Company wrote off unamortized deferred issuance fees and discounts of $1.6 and $2.2 during the three months ended December 31, 2024 and 2023, respectively, and $1.6 and $7.4 during the six months ended December 31, 2024 and 2023, respectively, which were recorded in Other expense (income), net in the Condensed Consolidated Statement of Operations. Additionally, the Company capitalized deferred issuance fees of $0.0 and $0.0 during the three months ended December 31, 2024 and 2023, respectively and $0.0 and $40.4 during the six months ended December 31, 2024 and 2023. Interest The 2018 Coty Credit Agreement facilities will bear interest at rates equal to, at the Company’s option, either: (1) SOFR of the applicable qualified currency, of which the Company can elect the applicable one, two, three, six or twelve month rate, plus the applicable margin; or (2) Alternate base rate (“ABR”) plus the applicable margin. In the case of the Coty Revolving Credit Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below: Pricing Tier Total Net Leverage Ratio: SOFR plus: Alternative Base Rate Margin: 1.0 Greater than or equal to 4.75:1 2.000% 1.000% 2.0 Less than 4.75:1 but greater than or equal to 4.00:1 1.750% 0.750% 3.0 Less than 4.00:1 but greater than or equal to 2.75:1 1.500% 0.500% 4.0 Less than 2.75:1 but greater than or equal to 2.00:1 1.250% 0.250% 5.0 Less than 2.00:1 but greater than or equal to 1.50:1 1.125% 0.125% 6.0 Less than 1.50:1 1.000% —% Pricing Tier Debt Ratings SOFR plus: Alternative Base Rate Margin: 5.0 Less than BB+/Ba1 2.000% 1.000% 4.0 BB+/Ba1 1.750% 0.750% 3.0 BBB-/Baa3 1.500% 0.500% 2.0 BBB/Baa2 1.250% 0.250% 1.0 BBB+/Baa1 or higher 1.125% 0.125% Fair Value of Debt December 31, 2024 June 30, 2024 Carrying Fair Carrying Fair Senior Secured Notes $ 3,369.3 $ 3,396.1 $ 3,716.7 $ 3,719.7 2018 Coty Credit Agreement 80.0 80.0 — — Senior Unsecured Notes — — 192.7 192.8 The fair value of the Coty Revolving Credit Facility is equal to its carrying value, as the Company has the ability to repay the outstanding principal at par value at any time. The Company uses the market approach to value its other debt instruments. The Company obtains fair values from independent pricing services or utilizes the U.S. dollar SOFR curve to determine the fair value of these debt instruments. Based on the assumptions used to value these liabilities at fair value, these debt instruments are categorized as Level 2 in the fair value hierarchy. Debt Maturities Schedule Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding short-term debt and finance lease obligations as of December 31, 2024, are presented below: Fiscal Year Ending June 30, 2025, remaining $ 10.0 2026 1,078.5 2027 520.4 2028 — 2029 1,090.4 Thereafter 750.0 Total $ 3,449.3 Covenants The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period. Quarterly Test Period Ending Total Net Leverage Ratio (a) December 31, 2024 through July 11, 2028 4.00 to 1.00 (a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, unusual events such as COVID-19, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement, as amended. In the four fiscal quarters following the closing of any Material Acquisition (as defined in the 2018 Coty Credit Agreement, as amended), including the fiscal quarter in which such Material Acquisition occurs, the maximum Total Net Leverage Ratio shall be the lesser of (i) 5.95 to 1.00 and (ii) 1.00 higher than the otherwise applicable maximum Total Net Leverage Ratio for such quarter (as set forth in the table above). Immediately after any such four fiscal quarter period, there shall be at least two consecutive fiscal quarters during which the Company's Total Net Leverage Ratio is no greater than the maximum Total Net Leverage Ratio that would otherwise have been required in the absence of such Material Acquisition, regardless of whether any additional Material Acquisitions are consummated during such period. As of December 31, 2024, the Company was in compliance with all covenants contained within the 2018 Coty Credit Agreement, as amended.

INTEREST EXPENSE, NET

INTEREST EXPENSE, NET	6 Months Ended
	Dec. 31, 2024
Interest Income (Expense), Operating [Abstract]
INTEREST EXPENSE, NET	INTEREST EXPENSE, NET Interest expense, net for the three and six months ended December 31, 2024 and 2023, respectively, is presented below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Interest expense $ 56.7 $ 61.7 $ 117.1 $ 128.5 Foreign exchange losses, net of derivative contracts 1.4 2.3 6.1 10.5 Interest income (3.7) (3.9) (7.0) (9.1) Total interest expense, net $ 54.4 $ 60.1 $ 116.2 $ 129.9

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	6 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
EMPLOYEE BENEFIT PLANS	EMPLOYEE BENEFIT PLANS The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below: Three Months Ended December 31, Pension Plans Other Post- U.S. International Total 2024 2023 2024 2023 2024 2023 2024 2023 Service cost — — 1.3 1.3 0.1 0.1 1.4 1.4 Interest cost 0.2 0.2 3.0 3.2 0.4 0.4 3.6 3.8 Expected return on plan assets — — (1.3) (1.2) — — (1.3) (1.2) Amortization of prior service credit — — — — — (0.1) — (0.1) Amortization of net (gain) loss — (0.2) (0.3) (0.6) (0.7) (0.6) (1.0) (1.4) Net periodic benefit cost (credit) 0.2 — 2.7 2.7 (0.2) (0.2) 2.7 2.5 Six Months Ended December 31, Pension Plans Other Post- U.S. International Total 2024 2023 2024 2023 2024 2023 2024 2023 Service cost — — 2.6 2.6 0.2 0.2 2.8 2.8 Interest cost 0.4 0.4 6.0 6.4 0.8 0.8 7.2 7.6 Expected return on plan assets — — (2.6) (2.4) — — (2.6) (2.4) Amortization of prior service credit — — — — — (0.2) — (0.2) Amortization of net (gain) loss — (0.4) (0.6) (1.2) (1.4) (1.2) (2.0) (2.8) Net periodic benefit cost (credit) 0.4 — 5.4 5.4 (0.4) (0.4) 5.4 5.0

DERIVATIVE INSTRUMENTS

DERIVATIVE INSTRUMENTS	6 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE INSTRUMENTS	DERIVATIVE INSTRUMENTS Foreign Exchange Risk The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. As of December 31, 2024 and June 30, 2024, the notional amount of the outstanding forward foreign exchange contracts designated as cash flow hedges were $20.9 and $22.3, respectively. The Company also uses certain derivatives not designated as hedging instruments consisting primarily of foreign currency forward contracts and cross-currency swaps to hedge intercompany transactions and foreign currency denominated external debt. Although these derivatives were not designated for hedge accounting, the overall objective of mitigating foreign currency exposure is the same for all derivative instruments. For derivatives not designated as hedging instruments, changes in fair value are recorded in the line item in the Condensed Consolidated Statements of Operations to which the derivative relates. As of December 31, 2024 and June 30, 2024, the notional amounts of these outstanding non-designated foreign currency forward contracts were $1,223.7 and $1,797.6, respectively. Interest Rate Risk The Company is exposed to interest rate fluctuations related to its variable rate debt instruments. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in the variable interest rates by entering into offsetting positions through the use of derivative instruments, such as interest rate swap contracts. The interest rate swap contracts result in recognizing a fixed interest rate for the portion of the Company’s variable rate debt that was hedged. This will reduce the negative and positive impact of increases in the variable rates over the term of the contracts. Hedge effectiveness of interest rate swap contracts is based on a long-haul hypothetical derivative methodology and includes all changes in value. In December 2023, the Company fully terminated interest rate swap contracts in the notional amount of $200.0 for a cash receipt of $2.1. As the forecasted interest expense under the original swap agreements is still probable, the related gain in accumulated other comprehensive income (loss) ("AOCI/L") will be amortized over the remaining life of the swaps. These interest rate swaps had been designated and qualified as cash flow hedges and were highly effective prior to termination. The Company had no outstanding interest rate swap contracts as of December 31, 2024. Net Investment Hedge Foreign currency gains and losses on borrowings designated as a net investment hedge, except ineffective portions, are reported in the cumulative translation adjustment (“CTA”) component of AOCI/(L), along with the foreign currency translation adjustments on those investments. As of December 31, 2024 and June 30, 2024, the nominal exposures of foreign currency denominated borrowings designated as net investment hedges were €2,249.2 million and €1,611.6 million, respectively. The designated hedge amounts were considered highly effective. Forward Repurchase Contracts In December 2022 and November 2023, the Company entered into certain forward repurchase contracts to start hedging for potential $196.0 and $294.0 share buyback programs, in 2025 and 2026, respectively. These forward repurchase contracts are accounted for at fair value, with changes in the fair value recorded in Other expense (income), net in the Condensed Consolidated Statements of Operations. In December 2024, the Company entered into an agreement to extend the maturity date of the December 2022 forward repurchase contracts by one year to 2026. Refer to Note 13—Equity and Convertible Preferred Stock. Derivative and non-derivative financial instruments which are designated as hedging instruments: The accumulated gain on foreign currency borrowings classified as net investment hedges in the foreign currency translation adjustment component of AOCI/(L) was $60.2 and $14.6 as of December 31, 2024 and June 30, 2024, respectively. In September 2020, the Company terminated its net investment cross-currency swap derivative with a notional amount of $550.0 in exchange for a cash payment of $37.6. The loss related to this termination of $(37.6) is included in AOCI/(L) as of December 31, 2024 and June 30, 2024, and will remain until the sale or substantial liquidation of the underlying net investments. The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended Six Months Ended 2024 2023 2024 2023 Foreign exchange forward contracts $ 1.7 $ (1.1) $ 1.1 $ — Interest rate swap contracts — (1.1) — (0.1) Net investment hedges 105.8 (27.6) 45.6 (9.9) The accumulated gain on derivative instruments classified as cash flow hedges in AOCI/(L), net of tax, was $1.6 and $2.1 as of December 31, 2024 and June 30, 2024, respectively. The estimated net gain related to these effective hedges that is expected to be reclassified from AOCI/(L) into earnings within the next twelve months is $1.6. As of December 31, 2024, all of the Company's remaining foreign currency forward contracts designated as hedges were highly effective. The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below: Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Three Months Ended December 31, 2024 2023 Cost of sales Interest expense, net Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ 0.7 $ — $ (1.4) $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — 0.4 — 0.6 Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Six Months Ended December 31, 2024 2023 Cost of sales Interest expense, net Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ 0.9 $ — $ (2.1) $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — 0.8 — 1.2 Derivatives not designated as hedging: The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below: Condensed Consolidated Statements of Operations Three Months Ended Six Months Ended 2024 2023 2024 2023 Foreign exchange contracts Selling, general and administrative expenses $ 0.3 $ (0.2) $ 0.4 $ (0.1) Foreign exchange contracts (a) Interest expense, net (50.4) 32.1 (22.8) 2.7 Foreign exchange and forward repurchase contracts Other income (expense), net (126.0) 72.1 (168.1) (3.6) (a) The losses and gains for these foreign exchange contracts were offset against the gains and losses from revaluation of debt denominated in foreign currency included in Interest expense, net .

EQUITY AND CONVERTIBLE PREFERRE

EQUITY AND CONVERTIBLE PREFERRED STOCK	6 Months Ended
	Dec. 31, 2024
Equity [Abstract]
EQUITY AND CONVERTIBLE PREFERRED STOCK	EQUITY AND CONVERTIBLE PREFERRED STOCK Common Stock As of December 31, 2024, the Company’s common stock consisted of Class A Common Stock with a par value of $0.01 per share. The holders of Class A Common Stock are entitled to one vote per share. As of December 31, 2024, total authorized shares of Class A Common Stock was 1,250.0 million and total outstanding shares of Class A Common Stock was 872.0 million. On September 29, 2023 and October 2, 2023, the Company issued a total of 33.0 million shares of Class A common stock, par value $0.01 per share, at a public offering price of $10.80 (or €10.28) per share in a global offering (the “Offering”). The Company also announced the admission to listing and trading of its Common Stock on the professional segment of the Euronext Paris. The Company received $348.4 from the Offering, net of $10.0 of underwriting fees. Additionally, the Company incurred $6.0 in other professional fees. The underwriting fees and other professional fees incurred in connection with the Offering were incremental costs directly attributable to the issuance and thus were presented as a reduction of Equity in the Condensed Consolidated Balance Sheets. The Company's Majority Stockholder As of December 31, 2024, JAB Beauty B.V. ("JAB"), the Company’s largest stockholder, may be deemed to beneficially own approximately 54% of Coty’s Class A Common Stock. This is inclusive of all voting interests of Mr. Peter Harf, the Company's Chairman, and HFS Holdings S.à r.l, (“HFS”), which is beneficially owned by Mr. Harf, including its shares of Convertible Series B Preferred Stock (the "Series B Preferred Stock") on an if converted basis. The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units on June 30, 2021. On October 29, 2021 and September 18, 2023, JAB completed the transfer of 10.0 million and 5.0 million shares of Common Stock, respectively, to Ms. Nabi pursuant to an equity transfer agreement. See Note 14—Share-Based Compensation Plans for additional information. Series A Preferred Stock As of December 31, 2024, total authorized shares of preferred stock are 20.0 million. There is one class of Preferred Stock, Series A Preferred Stock with a par value of $0.01 per share. As of December 31, 2024, there were 1.0 million shares of Series A authorized, issued, and outstanding. Series A Preferred Stock are not entitled to receive any dividends and have no voting rights except as required by law. On March 27, 2017, a Series A Preferred Stock subscription agreement was entered into with Lambertus J.H. Becht (“Mr. Becht”), the Company’s former Chairman of the Board. Under the terms provided in the subscription agreement, the Series A Preferred Stock immediately vested on the grant date and the holder was entitled to exchange the vested shares after the fifth anniversary of the date of issuance. This exchange right expired on March 27, 2024. The Company has the right to redeem the Series A Preferred Stock (1.0 million shares) at a redemption price of $0.01 per share. The Company plans to redeem these shares of Series A Preferred Stock in accordance with their terms. Convertible Series B Preferred Stock In 2020, the Company completed the issuance and sale to KKR Rainbow Aggregator L.P. (“KKR Aggregator”) of 1.0 million shares of Series B Preferred Stock, par value $0.01 per share, for an aggregate purchase price of $1,000 per share. On August 27, 2021, KKR Aggregator and its affiliated investment funds sold 146,057 shares of Series B Preferred Stock, to HFS, that is beneficially owned by Peter Harf, a director of the Company. As a result of various conversions and exchanges of KKR Aggregator's shares of the Series B Preferred Stock, as of December 31, 2021, Kohlberg Kravis Roberts & Co. L.P. and its affiliates ("KKR") has fully redeemed/exchanged all of their Series B Preferred Stock. Cumulative preferred dividends accrue daily on the Series B Preferred Stock at a rate of 9.0% per year. During the three months ended December 31, 2024 and 2023, the Board of Directors declared dividends on the Series B Preferred Stock of $3.3 and paid accrued dividends of $3.3. During the six months ended December 31, 2024 and 2023, the Board of Directors declared dividends on the Series B Preferred Stock of $6.6 and paid accrued dividends of $6.6. As of December 31, 2024 and June 30, 2024, the Series B Preferred Stock had outstanding accrued dividends of $3.3. Treasury Stock Share Repurchase Program Since February 2014, the Board has authorized the Company to repurchase its Class A Common Stock under approved repurchase programs. On February 3, 2016, the Board authorized the Company to repurchase up to $500.0 of its Class A Common Stock, and on November 13, 2023, the Board increased the Company's share repurchase authorization by an additional $600.0 (the “Share Repurchase Program”). Repurchases may be made from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its Class A Common Stock, and general market conditions. As of December 31, 2024, the Company has $796.8 remaining under the Share Repurchase Program. In December 2022 and November 2023, the Company entered into forward repurchase contracts (the “Forward” and together the “Forwards”) with three large financial institutions (“Counterparties”) to start hedging for potential $196.0 and $294.0 share buyback programs in 2025 and 2026, respectively. In December 2024, the Company entered into an agreement to extend the maturity date of the December 2022 forward repurchase contracts by one year to 2026. As part of the Forward agreements, the Company will pay interest on the outstanding underlying notional amount of the Forwards held by the Counterparties during the contract periods. The interest rates are variable, based on the United States secured overnight funding rate (“SOFR”) plus a spread. The weighted average interest rate plus applicable spread for the December 2022 and November 2023 Forward transactions were 9.5% and 7.9%, respectively, as of December 31, 2024. In addition, the Forwards include a provision for a potential true-up in cash upon specified changes in the price of the Company’s Class A Common Stock relative to the Initial Price (“Hedge Valuation Adjustment”). Such Hedge Valuation adjustment shall not result in a termination date or any adjustment of the number of Coty’s Class A Common Stock shares purchased by the Counterparties at inception. In October 2024, the price of Coty’s Class A shares declined below the threshold specified in the Hedge Valuation Adjustment for the November 2023 Forward, which resulted in a cash payment of $61.8 to the Counterparties. In November 2024, the Company entered into agreements with the Counterparties for a temporary contractual amendment to the Hedge Valuation Adjustment, which is effective from October 2024 through February 2025, resulting in a refund of $61.8 from the Counterparties. The amendment does not apply to the December 2022 Forward. Since the Forwards permit a net cash settlement alternative in addition to the physical settlement, the Company accounted for the Forwards initially and subsequently at their fair value, with changes in the fair value recorded in Other expense (income), net in the Condensed Consolidated Statement of Operations. See Note 12—Derivative Instruments for additional information. Dividends On April 29, 2020, the Board of Directors suspended the payment of dividends on Common Stock. No dividends on Common Stock were declared for the period ended December 31, 2024. The change in dividends accrued recorded to APIC in the Condensed Consolidated Balance Sheet as of December 31, 2024 and 2023 was nil, which represent dividends no longer expected to vest as a result of forfeitures of outstanding restricted stock units (“RSUs”). In addition, the Company made payments of $0.1 and $0.3, of which nil and $0.1 related to employee taxes, for the previously accrued dividends on RSUs that vested during the six months ended December 31, 2024 and 2023, respectively. Total accrued dividends on unvested RSUs and phantom units included in Accrued expenses and other current liabilities are $0.8 as of December 31, 2024 and June 30, 2024. Accumulated Other Comprehensive Income (Loss) Foreign Currency Translation Adjustments Gain on Cash Flow Hedges (Loss) gain on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans (a) Total Balance—July 1, 2024 $ 2.1 $ (23.0) $ (823.0) $ 48.8 $ (795.1) Other comprehensive income (loss) before reclassifications 0.7 45.6 (206.7) (1.2) (161.6) Net amounts reclassified from AOCI/(L) (1.2) — — (1.1) (2.3) Net current-period other comprehensive (loss) income (0.5) 45.6 (206.7) (2.3) (163.9) Balance—December 31, 2024 $ 1.6 $ 22.6 $ (1,029.7) $ 46.5 $ (959.0) (a) For the six months ended December 31, 2024, other comprehensive loss before reclassifications of $1.2 and net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial losses of $2.0, net of tax of $0.9. Foreign Currency Translation Adjustments Loss on Cash Flow Hedges Loss on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans Total Balance—July 1, 2023 $ 0.7 $ (49.8) $ (667.9) $ 54.6 $ (662.4) Other comprehensive (loss) income before reclassifications (0.1) (9.9) 66.8 1.0 57.8 Net amounts reclassified from AOCI/(L) 0.5 — — (2.5) (2.0) Net current-period other comprehensive income (loss) 0.4 (9.9) 66.8 (1.5) 55.8 Balance—December 31, 2023 $ 1.1 $ (59.7) $ (601.1) $ 53.1 $ (606.6)

SHARE-BASED COMPENSATION PLANS

SHARE-BASED COMPENSATION PLANS	6 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
SHARE-BASED COMPENSATION PLANS	SHARE-BASED COMPENSATION PLANS Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Equity plan expense (a) $ 15.2 $ 19.9 $ 32.1 $ 50.1 Liability plan (income) expense 0.3 0.3 0.4 (0.2) Fringe expense 2.9 3.1 2.9 3.1 Total share-based compensation expense $ 18.4 $ 23.3 $ 35.4 $ 53.0 (a) Equity plan share-based compensation expense was recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity. As of December 31, 2024, the total unrecognized share-based compensation expense related to stock options, restricted stock units and other share awards, and performance restricted stock units ("PRSUs") is $0.0, $130.0, and $36.0, respectively. The unrecognized share-based compensation expense related to stock options, restricted stock units and other share awards, and PRSUs, is expected to be recognized over a weighted-average period of 0.00, 2.23, and 3.08 years, respectively. Restricted Stock Units and Other Share Awards The Company granted 3.8 million shares and 4.5 million shares of RSUs and other share awards during the three and six months ended December 31, 2024 and 2023, respectively. The Company recognized share-based compensation expense of $17.6 and $19.3 for the three months ended December 31, 2024 and 2023, respectively, of which $5.2 and $5.2 related to Ms. Nabi's award, as described below. The Company recognized share-based compensation expense of $30.8 and $48.7 for the six months ended December 31, 2024 and 2023, respectively, of which $10.4 and $26.2 related to Ms. Nabi's award, as described below. Performance Restricted Stock Units The Company granted 4.0 and 4.1 million shares of PRSUs, during the three and six months ended December 31, 2024. The Company granted 1.6 and 3.7 million shares of PRSUs, during the three and six months ended December 31, 2023. The Company recognized share-based compensation expense of $0.8 and $3.2 for the three months ended December 31, 2024 and 2023, respectively, of which $0.1 and $1.7 related to Ms. Nabi's award, as described below. The Company recognized share-based compensation expense of $4.5 and $3.8 for the six months ended December 31, 2024 and 2023, respectively, of which $1.9 and $1.8 related to Ms. Nabi's award, as described below. Long-term Equity Program for CEO The Company’s CEO, Sue Nabi, was granted a one-time sign-on award of restricted stock units (the “Award”) on June 30, 2021. The Award vested and settled in 10.0 million shares of the Company’s Class A Common Stock, par value $0.01 per share, on each of August 31, 2021, August 31, 2022 and August 31, 2023. In connection with this Award, on October 29, 2021 and September 18, 2023, JAB, the Company’s largest stockholder and a wholly-owned subsidiary of JAB Holding Company S.à r.l., completed the transfer of 10.0 million and 5.0 million shares of Class A Common Stock, respectively, to Ms. Nabi. On August 31, 2023 and 2022, the Company issued 5.0 million and 10.0 million shares of Class A Common Stock, respectively, to Ms. Nabi in connection with the third and second vesting of the Award. Pursuant to the term of the amended employment agreement on May 4, 2023, the Company granted Ms. Nabi a one-time award of 10,416,667 RSUs and will grant a total of 10,416,665 PRSUs in five equal tranches over the next five years. These two awards will vest periodically over the next seven years in accordance with the terms discussed below. Ms. Nabi's 10,416,667 RSUs will vest and settle in shares of the Company’s Class A Common Stock, par value $0.01 per share over five years on the following vesting schedule: (i) 15% on September 1, 2024, (ii) 15% on September 1, 2025, (iii) 20% on September 1, 2026, (iv) 20% on September 1, 2027; and (v) 30% on September 1, 2028, in each case subject to Ms. Nabi’s continued employment through the applicable vesting date. The Company will recognize approximately $109.6 of share-based compensation expense, on a straight-line basis over the vesting period, based on the fair value on the grant date, net of forfeitures. The amount of compensation cost recognized at each vesting date must at least equal the portion of the award legally vested. The first and second tranche of Ms. Nabi's PRSU award of 2,083,333 shares each shall fully vest on September 1, 2026 and 2027, respectively, subject to the achievement of three-year performance objectives determined by the Board on September 28, 2023 and October 2, 2024 (the grant dates), respectively, and subject to Ms. Nabi’s continued employment. The next three tranches of 2,083,333 PRSUs will be granted on or around each September 1 of 2025 through 2027, which shall vest on the third-year anniversary of the respective grant date, subject in each case to the achievement of three-year performance objectives to be determined by the Board. The Company will recognize share-based compensation expense associated with these PRSUs, on a straight-line basis over the vesting period, based on the fair value on the grant date when it is probable that the performance condition will be achieved. In the event that JAB and Ms. Nabi sell shares of Common Stock for cash in a privately negotiated transaction, subject to Board approval, the Company will grant Ms. Nabi new options to acquire shares of Common Stock (the “Reload Options”) in an amount equal to the number of shares sold by Ms. Nabi in such transaction. The Reload Options will have a strike price equal to the greater of the volume weighted average price for shares at the time of the relevant transaction and the fair market value on the date of grant. The potential expense attributed to the Reload Options will be recognized when the Reload Options are granted. Restricted Stock The Company granted no shares of restricted stock during the three and six months ended December 31, 2024 and 0.3 million shares of restricted stock during the three and six months ended December 31, 2023. The Company recognized share-based compensation expense of $0.0 and $0.6 for the three months ended December 31, 2024 and 2023, respectively, and $0.0 and $1.1 for the six months ended December 31, 2024 and 2023, respectively. Series A Preferred Stock The Company granted no shares of Series A Preferred Stock during the three and six months ended December 31, 2024 and 2023. The Company recognized share-based compensation (income) expense of $0.0 and $(0.1) for the three months ended December 31, 2024 and 2023, respectively, and $0.0 and $(0.7) for the six months ended December 31, 2024 and 2023, respectively. Non-Qualified Stock Options The Company granted no non-qualified stock options during the three and six months ended December 31, 2024 and 2023. The Company recognized share-based compensation expense (income) of nil and $0.3 for the three months ended December 31, 2024 and 2023, respectively, and $0.1 and $0.1 for the six months ended December 31, 2024 and 2023, respectively.

NET INCOME ATTRIBUTABLE TO COTY

NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE	6 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE	NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Amounts attributable to Coty Inc.: Net income attributable to Coty Inc. $ 23.7 $ 180.9 $ 106.6 $ 182.5 Convertible Series B Preferred Stock dividends (3.3) (3.3) (6.6) (6.6) Net income (loss) attributable to common stockholders $ 20.4 $ 177.6 $ 100.0 $ 175.9 Weighted-average common shares outstanding: Weighted-average common shares outstanding—Basic 871.4 892.8 869.6 873.6 Effect of dilutive stock options and Series A Preferred Stock (a) — — — 0.1 Effect of restricted stock and RSUs (b) 3.8 6.3 5.6 9.6 Effect of Convertible Series B Preferred Stock (c) — 23.7 — — Effect of Forward Repurchase Contracts (d) — — — — Weighted-average common shares outstanding—Diluted 875.2 922.8 875.2 883.3 Earnings per common share: Earnings per common share - basic $ 0.02 $ 0.20 $ 0.11 $ 0.20 Earnings per common share - diluted (e) 0.02 0.20 0.11 0.20 (a) For the three months ended December 31, 2024 and 2023, outstanding stock options with rights to purchase 3.5 million and 3.9 million shares of Common Stock were anti-dilutive and excluded from the computation of diluted EPS. Series A Preferred Stock had no dilutive effect, as the exchange right expired on March 27, 2024. For the six months ended December 31, 2024 and 2023, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 3.5 million and 2.9 million weighted average shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. (b) For the three months ended December 31, 2024 and 2023, there were 13.7 million and 3.9 million anti-dilutive RSUs, respectively, excluded from the computation of Diluted EPS. For the three months ended December 31, 2024 and 2023, there were no restricted stock outstanding. For the six months ended December 31, 2024 and 2023, there were 6.8 million and 2.0 million weighted average anti-dilutive RSUs, respectively, excluded from the computation of diluted EPS. (c) For the three and six months ended December 31, 2024, no dilutive shares of Convertible Series B Preferred Stock were included in the computation of diluted EPS as their inclusion would be anti-dilutive. For the three months ended December 31, 2023, there were 23.7 million dilutive shares of Convertible Series B Preferred Stock included in the computation of diluted EPS as their inclusion would be dilutive. For the six months ended December 31, 2023, no dilutive shares of Convertible Series B Preferred Stock were included in the computation of diluted EPS as their inclusion would be anti-dilutive. (d) For the three and six months ended December 31, 2024 and 2023, no dilutive shares of the Forward Repurchase Contracts were included in the computation of diluted EPS as their inclusion would be anti-dilutive. (e) Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans, the convertible Series B Preferred Stock, and the Forward Repurchase Contracts. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock, RSUs and PRSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock and the Forward Repurchase Contracts. The treasury method typically does not adjust the net income attributable to Coty Inc., while the if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $3.3, and to reverse the impact of fair market value losses/(gains) for contracts with the option to settle in shares or cash of $96.5 and $(44.4), respectively, if dilutive, for the three months ended December 31, 2024 and 2023 on net income applicable to common stockholders during the period. The if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $6.6, and to reverse the impact of fair market value losses/(gains) for contracts with the option to settle in shares or cash of $128.8 and $(0.2) respectively, if dilutive, for the six months ended December 31, 2024 and 2023 on net income applicable to common stockholders during the period.

REDEEMABLE NONCONTROLLING INTER

REDEEMABLE NONCONTROLLING INTERESTS	6 Months Ended
	Dec. 31, 2024
Noncontrolling Interest [Abstract]
REDEEMABLE NONCONTROLLING INTERESTS	REDEEMABLE NONCONTROLLING INTERESTS Subsidiary in the Middle East As of December 31, 2024, the noncontrolling interest holder in the Company’s subsidiary in the Middle East had a 25% ownership share. The Company adjusts the redeemable noncontrolling interests (“RNCI”) to redemption value at the end of each reporting period with changes recognized as adjustments to APIC. The Company recognized $103.1 and $93.6 as the RNCI balances as of December 31, 2024 and June 30, 2024, respectively.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	COMMITMENTS AND CONTINGENCIES Legal Matters The Company is involved, from time to time, in various litigation, administrative and other legal proceedings, including regulatory actions, incidental or related to its business, including consumer class or collective actions, personal injury (mostly involving allegations related to alleged asbestos in the Company’s talc-based cosmetic products as described below), intellectual property, competition, compliance and advertising claims litigation and disputes, among others (collectively, “Legal Proceedings”). While the Company cannot predict any final outcomes relating thereto, management believes that the outcome of current Legal Proceedings will not have a material effect upon its business, prospects, financial condition, results of operations, cash flows or the trading price of the Company’s securities. However, management’s assessment of the Company’s current Legal Proceedings is ongoing, and could change in light of the discovery of additional facts with respect to Legal Proceedings not presently known to the Company, further legal analysis, or determinations by judges, arbitrators, juries or other finders of fact or deciders of law which are not in accord with management’s evaluation of the probable liability or outcome of such Legal Proceedings. From time to time, the Company is in discussions with regulators, including discussions initiated by the Company, about actual or potential violations of law in order to remediate or mitigate associated legal or compliance risks and liabilities or penalties. As the outcomes of such proceedings are unpredictable, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, prospects, financial condition, results of operations, cash flows or the trading price of its securities. Cosmetic Talcum Powder Matters. The Company has been named as a defendant in numerous civil actions alleging that certain cosmetic talcum powder products sold by the Company were contaminated with asbestos leading to bodily injury. Most of these actions involve a number of co-defendants and, to date, many such actions have been resolved by settlement or other resolution acceptable to the Company. In each of the previous fiscal years the value of settlements, both individually and in the aggregate, has not been material but, due to the rising number of filed and pending cases against the Company, as well as the evolving litigation landscape, settlement values and other costs associated with these cases are likely to increase in the future. The Company believes that a limited portion of its costs incurred in defending and resolving certain of these claims will be covered by insurance policies issued by several insurance carriers, subject to deductibles, exclusions, retentions and policy limits and in some cases there may be indemnity obligations of third parties. While the Company and its legal counsel intend to continue to defend these cases vigorously, there can be no assurances regarding the ultimate resolution of these matters, individually or collectively. The Company has accrued for such litigation when the likelihood of loss is probable and a reasonable estimate of such loss can be made, and such accruals are not material to the Company’s condensed consolidated financial statements. However, the range of reasonably possible losses in excess of accrued liabilities currently cannot be reasonably estimated. Brazilian Tax Assessments The Company’s Brazilian subsidiaries receive tax assessments from local, state and federal tax authorities in Brazil from time to time. Current open tax assessments as of December 31, 2024 are: Assessment received Type of assessment Type of Tax Tax period impacted Estimated amount, including interest and penalties as of December 31, 2024 Aug-20 State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered ICMS 2017-2019 R$684.0 million (approximately $110.7) Oct-20 Federal excise taxes, which the Treasury Office of the Brazil’s Internal Revenue Service considers as improperly calculated IPI 2016-2017 R$454.0 million (approximately $73.5) Nov-22 IPI 2018-2019 R$616.2 million (approximately $99.7) Mar-24 IPI 2020 R$34.8 million (approximately $5.6) Nov-20 State sales taxes, which the Treasury Office of the State of Minas Gerais considers as improperly calculated ICMS 2016-2019 R$234.6 million (approximately $38.0) Jun-21 State sales tax, which the Treasury Office of the State of Goiás considers as improperly calculated ICMS 2016-2020 R$55.0 million (approximately $8.9) For the Goiás State tax ICMS assessment received in August 2020, the Company has in parallel a judicial case about an additional claim for fees over the tax incentive ("the Protege Fee") wherein the Company asserts such fee was not enforceable against Coty due to its prior contractual agreement with the Goiás State, for which the Company received an unfavorable first and second instances ruling. In the second quarter of fiscal 2024, the Company filed appeals to be remitted to the third instance Brazilian Superior Court of Justice and, in parallel, filed a motion to grant the suspension of the state's ability to collect the above tax incentives to the Goiás State Court as the case is under discussion. The motion to grant the suspension of the state’s ability to collect the above tax incentives was dismissed and, in the last quarter of fiscal 2024, a judge of the Superior Court of Justice ruled against the Company. The Company filed an interlocutory appeal for the full bench of judges on the Superior Court of Justice to review the case. The case was heard in the first half of the current fiscal year, but the case is on hold for review by one of the judges and is now expected to conclude in the second half of the current fiscal year. The Company has been required to provide surety bonds of R$135.2 million (approximately $21.9) and cash deposits of R$152.6 million (approximately $24.7) as of December 31, 2024, to guarantee payment if the case is resolved against Coty. The cash deposits are included in the Other Noncurrent Assets on the Condensed Consolidated Balance Sheet. In relation to the judicial case for the Goiás State tax ICMS assessment received in August 2020, an additional case has moved into the judicial court in October 2024, relating to a tax assessment demanding payment of the underlying ICMS taxes due to non-payment of the Protege Fee. The case is running in parallel of the Protege Fee case above and is in an early stage. The Company has been required to provide surety bonds of R$446.2 million (approximately $72.2) as of December 31, 2024, to guarantee payment if the case is resolved against Coty. The Minas Gerais State tax ICMS assessment received in November 2020 is currently at the judicial process. The Company has been required to provide surety bonds of R$311.9 million (approximately $50.5) as of December 31, 2024, to guarantee payment if the case is resolved against the Company. All other cases are currently in the administrative process. The Company expects that cases may move from the administrative to the judicial process in case Coty does not receive a favorable decision at the administrative level, although the exact timing is uncertain. For cases in the judicial process, the Company will be required to make a judicial deposit or enter into a surety bond for the disputed tax assessment, interest and penalties. The judicial process in Brazil is likely to take a number of years to conclude. The Company is seeking favorable judicial and administrative decisions on the tax enforcement actions filed by the tax authorities for these assessments. The Company believes it has meritorious defenses and it has not recognized a loss for these assessments as the Company does not believe a loss is probable.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Dec. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	RELATED PARTY TRANSACTIONS Wella On December 22, 2021, the Company entered into an agreement with Rainbow UK Bidco Limited (“KKR Bidco”) (an affiliate of funds and/or separately managed accounts advised and/or managed by KKR), related to post-closing adjustments to the purchase consideration for the Coty’s Professional and Retail Hair businesses, including the Wella, Clairol, OPI and ghd brands, (together, the “Wella Business”). In relation to this agreement, the Company recognized a gain of $3.7 and $4.6 in the three and six months ended December 31, 2024, and $1.9 and $8.5 in the three and six months ended December 31, 2023, which is reported in Other expense (income), net in the Condensed Consolidated Statements of Operations. During the six months ended December 31, 2024, net cash proceeds received from this contingent consideration arrangement totaled $15.6. As of December 31, 2024, Coty owned 25.84% of Wella as an equity investment and performs certain services to Wella. Refer to Note 6— Equity Investments. In connection with the sale of the Wella Business, the Company and Wella entered into a Transitional Services Agreement (“TSA”) and the Company performed services for Wella in exchange for related service fees. The Company and Wella have mutually agreed to end the contracted TSA services on January 31, 2022, as well as previously existing distribution services in Brazil during the third quarter of fiscal 2024. The Company and Wella continue to have in place manufacturing arrangements to facilitate the Wella Business transition in the U.S. and Brazil. TSA fees and other fees earned were $0.1 and $1.6, respectively, for the three months ended December 31, 2024 and $0.8 and $2.7, respectively, for the three months ended December 31, 2023. TSA fees and other fees earned were $0.1 and $3.0, respectively, for the six months ended December 31, 2024 and $1.8 and $5.0, respectively, for the six months ended December 31, 2023. Fees are principally invoiced on a cost plus basis and were included in Selling, general and administrative expenses and Cost of sales, respectively, in the Company's Condensed Consolidated Statement of Operations. The Company also entered into an agreement with Wella to provide management, consulting and financial services. The Company earned $0.4 and $0.7 in the three and six months ended December 31, 2024, respectively, and $0.3 and $0.6 in the three and six months ended December 31, 2023, respectively, which are reflected in Other expense (income), net in the Condensed Consolidated Statements of Operations. As of December 31, 2024, accounts receivable from and accounts payable to Wella of $26.7 and $0.1, respectively, were included in Prepaid expenses and other current assets and Accrued expenses and other current liabilities, respectively, in the Company's Condensed Consolidated Balance Sheets. Additionally, as of December 31, 2024, the Company has accrued $33.0 related to long-term payables due to Wella included in Other noncurrent liabilities in the Company's Condensed Consolidated Balance Sheet. Coty will continue to recognize the share-based compensation expense for Wella employees until the existing equity awards reach their vesting date. For the three and six months ended December 31, 2024, Coty recorded $0.3 and $0.7, respectively, and for the three and six months ended December 31, 2023, Coty recorded $0.6 and $1.3, respectively, of share-based compensation expense related to Wella employees, which was presented as part of Other expense (income), net in the Condensed Consolidated Statements of Operations.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Dec. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	SUBSEQUENT EVENTS The Company evaluated the effect of events and transactions subsequent to the condensed consolidated balance sheet date of December 31, 2024 through the date of issuance of the Condensed Consolidated Financial Statements and determined that no subsequent events have occurred that require recognition in the Condensed Consolidated Financial Statements or disclosure in the notes to the Condensed Consolidated Financial Statements.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss) Attributable to Parent	$ 23.7	$ 180.9	$ 106.6	$ 182.5

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Fiscal Period	The Company operates on a fiscal year basis with a year-end of June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2025” refer to the fiscal year ending June 30, 2025.
Basis of Presentation	Basis of Presentation The unaudited interim Condensed Consolidated Financial Statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and include the Company’s consolidated domestic and international subsidiaries. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited interim Condensed Consolidated Financial Statements and accompanying footnotes should be read in conjunction with the Company’s Consolidated Financial Statements as of and for the year ended June 30, 2024. In the opinion of management, all adjustments, of a normal recurring nature, considered necessary for a fair presentation have been included in the Condensed Consolidated Financial Statements. The results of operations for the three and six months ended December 31, 2024 are not necessarily indicative of the results of operations to be expected for the full fiscal year ending June 30, 2025. All dollar amounts (other than per share amounts) in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.
Restricted Cash	Restricted Cash
Equity Investments	Equity Investments The Company elected the fair value option to account for its investment in Rainbow JVCO LTD and subsidiaries (together, "Wella" or the “Wella Company”) to align with the Company’s strategy for this investment. The fair value is updated on a quarterly basis. The investment is classified within Level 3 in the fair value hierarchy because the Company estimates the fair value of the investment using a combination of the income approach, the market approach and private transactions, when applicable. Changes in the fair value of equity investment under the fair value option are recorded in Other expense (income), net within the Condensed Consolidated Statements of Operations (see Note 6—Equity Investments).
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the period reported. Significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, the net realizable value of inventory, the fair value of equity investments, the assessment of goodwill, other intangible assets and long-lived assets for impairment and income taxes. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, and makes adjustments when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ significantly from those estimates and assumptions. Significant changes, if any, in those estimates and assumptions will be reflected in the Condensed Consolidated Financial Statements in future periods.
Tax Information	Tax Information The effective income tax rate for the three and six months ended December 31, 2024 and 2023 was 45.9% and 27.7%, respectively, and 35.9% and 36.4%, respectively. The change in the effective tax rate for the three months ended December 31, 2024, as compared with the three months ended December 31, 2023 is primarily attributable to the loss on forward repurchase contracts having a higher proportional impact in the current period, as well as the impact of fair value losses related to the investment in Wella taxed at a rate below the statutory rate of 21% in the current period. The change in the effective rate for the six months ended December 31, 2024, as compared with the six months ended December 31, 2023, is primarily due to the impact of a higher effective tax rate in the prior period related to the revaluation of the Company’s deferred tax liabilities due to a tax rate increase enacted in Switzerland resulting in an expense of $24.3. The effective tax rate of 45.9% for the three months ended December 31, 2024 was higher than the Federal statutory rate of 21% primarily due to the limitation on the deductibility of executive stock compensation and the limitation on the deductibility of interest expense as well as the impact of fair value losses related to the investment in Wella taxed at a rate below the statutory rate of 21%. The effective tax rate of 27.7% in the three months ended December 31, 2023 was higher than the Federal statutory rate of 21% primarily due to the limitation on the deductibility of executive stock compensation. The effective tax rate of 35.9% in the six months ended December 31, 2024 was higher than the statutory tax rate of 21% due to the limitation on the deductibility of executive stock compensation and the limitation on the deductibility of interest expense as well as the impact of fair value losses related to the investment in Wella taxed at a rate below the statutory rate of 21%. The effective tax rate of 36.4% in the six months ended December 31, 2023 was higher than the statutory tax rate of 21% primarily due to an expense of $24.3 in the period recognized on the revaluation of the Company's deferred tax liabilities due to a tax rate increase enacted in Switzerland. The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, including impacts of rate changes, (ii) adjustments to the Company’s unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses . Additionally, in January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. The standard requires, in the notes to the financial statements, disclosure of specified information about certain costs and expenses, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization from each relevant expense caption. The amendments in ASU 2024-03 are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption and retrospective application are permitted, but not required. The Company plans to adopt the standard and make the additional required annual disclosures beginning in the fourth quarter of fiscal 2028 and the required interim disclosures beginning in the first quarter of fiscal 2029. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which expands reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity discloses, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker ("CODM"), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. Annual disclosures are required for the Company in fiscal 2025. Interim disclosures are required for periods within fiscal years beginning in the first quarter of fiscal 2026. Retrospective application is required for all prior periods presented, and early adoption is permitted. The Company will adopt the standard and make the additional required disclosures beginning in the fourth quarter of fiscal 2025.
Derivative Instruments	Foreign Exchange Risk The Company is exposed to foreign currency exchange fluctuations through its global operations. The Company may reduce its exposure to fluctuations in the cash flows associated with changes in foreign exchange rates by creating offsetting positions through the use of derivative instruments and also by designating foreign currency denominated borrowings and cross-currency swaps as hedges of net investments in foreign subsidiaries. The Company expects that through hedging, any gain or loss on the derivative instruments would generally offset the expected increase or decrease in the value of the underlying forecasted transactions. Interest Rate Risk

SEGMENT REPORTING (Tables)

SEGMENT REPORTING (Tables)	6 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of reportable segments	Three Months Ended Six Months Ended SEGMENT DATA 2024 2023 2024 2023 Net revenues: Prestige $ 1,116.1 $ 1,122.6 $ 2,230.2 $ 2,187.3 Consumer Beauty 553.8 605.0 1,111.2 1,181.7 Total $ 1,669.9 $ 1,727.6 $ 3,341.4 $ 3,369.0 Operating income (loss): Prestige 222.3 200.6 463.8 422.2 Consumer Beauty 64.1 60.4 78.1 92.4 Corporate (18.2) (24.3) (35.9) (80.4) Total $ 268.2 $ 236.7 $ 506.0 $ 434.2 Reconciliation: Operating income 268.2 236.7 506.0 434.2 Interest expense, net 54.4 60.1 116.2 129.9 Other expense (income), net 157.2 (80.8) 200.5 (4.2) Income before income taxes $ 56.6 $ 257.4 $ 189.3 $ 308.5
Schedule of percentage of revenues associated with product categories	Presented below are the percentage of net revenues associated with the Company’s product categories: Three Months Ended Six Months Ended PRODUCT CATEGORY 2024 2023 2024 2023 Fragrance 70.6 % 67.3 % 70.4 % 66.9 % Color Cosmetics 22.3 24.1 22.2 24.3 Body Care & Other 4.4 5.7 4.5 5.7 Skincare 2.7 2.9 2.9 3.1 Total 100.0 % 100.0 % 100.0 % 100.0 %

RESTRUCTURING COSTS (Tables)

RESTRUCTURING COSTS (Tables)	6 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of restructuring costs	Restructuring costs for the three and six months ended December 31, 2024 and 2023 are presented below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Total Restructuring Actions $ 1.4 $ 5.7 $ 2.1 $ 34.1

INVENTORIES (Tables)

INVENTORIES (Tables)	6 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Schedule of inventory	Inventories as of December 31, 2024 and June 30, 2024 are presented below: December 31, June 30, Raw materials $ 197.4 $ 201.2 Work-in-process 11.0 10.4 Finished goods 497.4 552.5 Total inventories $ 705.8 $ 764.1

EQUITY INVESTMENTS (Tables)

EQUITY INVESTMENTS (Tables)	6 Months Ended
	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of equity investments	The Company's equity investments, classified as Equity investments in the Condensed Consolidated Balance Sheets are represented by the following: December 31, June 30, Equity method investments: KKW Holdings (a) $ 3.7 $ 5.6 Equity investments at fair value: Wella (b) 1,053.0 1,085.0 Total equity investments $ 1,056.7 $ 1,090.6 (a) On January 4, 2021, the Company completed its purchase of 20% of the outstanding equity of KKW Holdings. The Company accounts for this minority investment under the equity method, given it has the ability to exercise significant influence over, but not control, the investee. The carrying value of the Company’s investment includes basis differences allocated to amortizable intangible assets. The Company recognized $0.9 and $0.9, respectively, during the three months ended December 31, 2024 and 2023, and $1.9 and $1.7 respectively, during the six months ended December 31, 2024 and 2023 representing its share of the investee’s net loss in Other expense (income), net within the Condensed Consolidated Statements of Operations. (b) As of December 31, 2024 and June 30, 2024, the Company's stake in Wella was 25.84%. The following table presents summarized financial information of the Company’s equity method investees for the period ending December 31, 2024. Amounts presented represent combined totals at the investee level and not the Company’s proportionate share: Three Months Ended Six Months Ended 2024 2023 2024 2023 Summarized Statements of Operations information: Net revenues $ 737.9 $ 703.9 $ 1,393.4 $ 1,341.2 Gross profit 507.4 472.1 953.1 898.9 Operating income 109.1 79.6 147.8 124.5 Income before income taxes 51.3 24.2 48.8 17.4 Net income (loss) 19.2 74.2 (6.9) 57.5
Schedule of movement in equity investments	The following table summarizes movements in equity investments with fair value option that are classified within Level 3 for the period ended December 31, 2024. There were no internal movements to or from Level 3 and Level 1 or Level 2 for the period ended December 31, 2024. Equity investments at fair value: Balance as of June 30, 2024 $ 1,085.0 Total losses included in earnings (32.0) Balance as of December 31, 2024 $ 1,053.0
Schedule of significant unobservable inputs used in Level 3 valuation	The following table summarizes the significant unobservable inputs used in Level 3 valuation of the Company's investments carried at fair value as of December 31, 2024. Included in the table are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments. Fair value Valuation technique Unobservable Range Equity investments at fair value $ 1,053.0 Discounted cash flows Discount rate 9.50% (a) Growth rate 2.0% - 7.1% (a) Market multiple Revenue multiple 1.8x – 2.0x (b) EBITDA multiple 10.1x – 11.9x (b) (a) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a discounted cash flow method, are the discount rate and revenue growth rate. Significant increases (decreases) in the discount rate in isolation would result in a significantly lower (higher) fair value measurement. The Company estimates the discount rate based on the investees' projected cost of equity and debt. The revenue growth rate is forecasted for future years by the investee based on their best estimates. Significant increases (decreases) in the revenue growth rate in isolation would result in a significantly higher (lower) fair value measurement. (b) The primary unobservable inputs used in the fair value measurement of the Company's equity investments with fair value option, when using a market multiple method, are the revenue multiple and EBITDA multiple. Significant increases (decreases) in the revenue multiple or EBITDA multiple in isolation would result in a significantly higher (lower) fair value measurement. The market multiples are derived from a group of guideline public companies.

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS, NET (Tables)	6 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of goodwill	Goodwill as of December 31, 2024 and June 30, 2024 is presented below: Prestige Consumer Beauty Total Gross balance at June 30, 2024 $ 6,214.6 $ 1,731.2 $ 7,945.8 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at June 30, 2024 $ 3,104.3 $ 801.4 $ 3,905.7 Changes during the period ended December 31, 2024 Foreign currency translation (70.5) (18.8) (89.3) Gross balance at December 31, 2024 $ 6,144.1 $ 1,712.4 $ 7,856.5 Accumulated impairments (3,110.3) (929.8) (4,040.1) Net balance at December 31, 2024 $ 3,033.8 $ 782.6 $ 3,816.4
Schedule of indefinite-lived intangible assets	Other intangible assets, net as of December 31, 2024 and June 30, 2024 are presented below: December 31, June 30, Indefinite-lived other intangible assets $ 935.0 $ 944.6 Finite-lived other intangible assets, net 2,483.4 2,621.0 Total Other intangible assets, net $ 3,418.4 $ 3,565.6 The changes in the carrying amount of indefinite-lived other intangible assets are presented below: Trademarks Total Gross balance at June 30, 2024 $ 1,889.5 $ 1,889.5 Accumulated impairments (944.9) (944.9) Net balance at June 30, 2024 $ 944.6 $ 944.6 Changes during the period ended December 31, 2024 Foreign currency translation (9.6) (9.6) Gross balance at December 31, 2024 $ 1,879.9 $ 1,879.9 Accumulated impairments (944.9) (944.9) Net balance at December 31, 2024 $ 935.0 $ 935.0
Schedule of finite-lived intangible assets	Other intangible assets, net as of December 31, 2024 and June 30, 2024 are presented below: December 31, June 30, Indefinite-lived other intangible assets $ 935.0 $ 944.6 Finite-lived other intangible assets, net 2,483.4 2,621.0 Total Other intangible assets, net $ 3,418.4 $ 3,565.6 Intangible assets subject to amortization are presented below: Cost Accumulated Amortization Accumulated Impairment Net June 30, 2024 License agreements and collaboration agreements $ 3,715.1 $ (1,422.5) $ (19.6) $ 2,273.0 Customer relationships 741.8 (527.8) (5.5) 208.5 Trademarks 311.7 (192.4) (0.5) 118.8 Product formulations and technology 83.7 (63.0) — 20.7 Total $ 4,852.3 $ (2,205.7) $ (25.6) $ 2,621.0 December 31, 2024 License agreements and collaboration agreements $ 3,656.0 $ (1,476.3) $ (19.6) $ 2,160.1 Customer relationships 731.4 (534.1) (5.5) 191.8 Trademarks 309.9 (197.5) (0.5) 111.9 Product formulations and technology 81.5 (61.9) — 19.6 Total $ 4,778.8 $ (2,269.8) $ (25.6) $ 2,483.4

LEASES (Tables)

LEASES (Tables)	6 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Schedule of lease cost	The following chart provides additional information about the Company’s operating leases: Three Months Ended Six Months Ended Lease Cost: 2024 2023 2024 2023 Operating lease cost $ 19.4 $ 18.7 $ 38.2 $ 37.8 Short-term lease cost 0.7 0.5 1.4 0.8 Variable lease cost 10.7 8.9 22.4 19.6 Sublease income (3.8) (4.5) (7.4) (8.4) Net lease cost $ 27.0 $ 23.6 $ 54.6 $ 49.8 Other information: Operating cash outflows from operating leases $ (18.1) $ (18.0) $ (34.9) $ (37.2) Right-of-use assets obtained in exchange for lease obligations $ 0.5 $ 17.7 $ 19.1 $ 32.7 Weighted-average remaining lease term - real estate 6.5 years 6.9 years Weighted-average discount rate - real estate leases 4.54 % 4.42 %
Schedule of future minimum lease payments for operating leases	Future minimum lease payments for the Company’s operating leases are as follows: Fiscal Year Ending June 30, 2025, remaining $ 35.3 2026 60.1 2027 52.6 2028 40.0 2029 34.8 Thereafter 80.3 Total future lease payments $ 303.1 Less: imputed interest (43.6) Total present value of lease liabilities $ 259.5 Current operating lease liabilities 56.2 Long-term operating lease liabilities 203.3 Total operating lease liabilities $ 259.5

DEBT (Tables)

DEBT (Tables)	6 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of debt	The Company’s debt balances consisted of the following as of December 31, 2024 and June 30, 2024, respectively: December 31, June 30, Short-term debt $ 1.5 $ — Senior Secured Notes (a) 2026 Dollar Senior Secured Notes due April 2026 350.0 650.0 2026 Euro Senior Secured Notes due April 2026 728.5 748.1 2027 Euro Senior Secured Notes due May 2027 520.4 534.3 2028 Euro Senior Secured Notes due September 2028 520.4 534.3 2029 Dollar Senior Secured Notes due January 2029 500.0 500.0 2030 Dollar Senior Secured Notes due July 2030 750.0 750.0 2018 Coty Credit Agreement Coty Revolving Credit Facility due July 2028 (b) 80.0 — Senior Unsecured Notes 2026 Euro Notes due April 2026 — 192.7 Finance lease obligations & other long term debt 8.2 4.3 Total debt 3,459.0 3,913.7 Less: Short-term debt and current portion of long-term debt (14.4) (3.0) Total Long-term debt 3,444.6 3,910.7 Less: Unamortized financing fees and discounts on long-term debt (57.6) (68.9) Total Long-term debt, net $ 3,387.0 $ 3,841.8 (a) As described further below, a covenant suspension period is in effect for each of the Senior Secured Notes, and in certain cases a collateral release, due to the achievement of investment grade ratings for such notes in September 2024. (b) The current portion of long-term debt includes swingline loans outstanding under the Company's revolving credit facility of $10.0 and $0.0 as of December 31, 2024 and June 30, 2024, respectively.
Schedule of debt instrument redemption	At any time on or after the Early Redemption Dates, the Company may redeem some or all of the respective notes at the redemption prices (expressed in percentage of principal amount) set forth below, plus accrued and unpaid interest, if any, to, but excluding, the redemption dates, if redeemed during the twelve-month period beginning on respective dates of each of the years indicated below: Price For the period beginning 2026 Dollar Senior Secured Notes 2026 Euro Senior Secured Notes 2027 Euro Senior Secured Notes 2028 Euro Senior Secured Notes 2029 Dollar Senior Secured Notes 2030 Dollar Senior Secured Notes Year April 15, May 15, November 15, September 15 January 15, July 15, 2025 100.000% 100.000% N/A N/A 102.875% 102.375% N/A 2026 N/A N/A 102.250% 100.000% 101.438% 101.188% 103.313% 2027 N/A N/A 100.000% N/A 100.000% 100.000% 101.656% 2028 and thereafter N/A N/A N/A N/A 100.000% 100.000% 100.000%
Schedule of total net leverage ratio requirement	In the case of the Coty Revolving Credit Facility, the applicable margin means the lesser of a percentage per annum to be determined in accordance with the leverage-based pricing grid and the debt rating-based grid below: Pricing Tier Total Net Leverage Ratio: SOFR plus: Alternative Base Rate Margin: 1.0 Greater than or equal to 4.75:1 2.000% 1.000% 2.0 Less than 4.75:1 but greater than or equal to 4.00:1 1.750% 0.750% 3.0 Less than 4.00:1 but greater than or equal to 2.75:1 1.500% 0.500% 4.0 Less than 2.75:1 but greater than or equal to 2.00:1 1.250% 0.250% 5.0 Less than 2.00:1 but greater than or equal to 1.50:1 1.125% 0.125% 6.0 Less than 1.50:1 1.000% —% Pricing Tier Debt Ratings SOFR plus: Alternative Base Rate Margin: 5.0 Less than BB+/Ba1 2.000% 1.000% 4.0 BB+/Ba1 1.750% 0.750% 3.0 BBB-/Baa3 1.500% 0.500% 2.0 BBB/Baa2 1.250% 0.250% 1.0 BBB+/Baa1 or higher 1.125% 0.125% The 2018 Coty Credit Agreement contains affirmative and negative covenants. The negative covenants include, among other things, limitations on debt, liens, dispositions, investments, fundamental changes, restricted payments and affiliate transactions. With certain exceptions as described below, the 2018 Coty Credit Agreement, as amended, includes a financial covenant that requires us to maintain a Total Net Leverage Ratio (as defined below), equal to or less than the ratios shown below for each respective test period. Quarterly Test Period Ending Total Net Leverage Ratio (a) December 31, 2024 through July 11, 2028 4.00 to 1.00 (a) Total Net Leverage Ratio means, as of any date of determination, the ratio of: (a) (i) Total Indebtedness minus (ii) unrestricted and Cash Equivalents of the Parent Borrower and its Restricted Subsidiaries as determined in accordance with GAAP to (b) Adjusted EBITDA for the most recently ended Test Period (each of the defined terms, including Adjusted EBITDA, used within the definition of Total Net Leverage Ratio have the meanings ascribed to them within the 2018 Coty Credit Agreement, as amended). Adjusted EBITDA, as defined in the 2018 Coty Credit Agreement, as amended, includes certain add backs related to cost savings, unusual events such as COVID-19, operating expense reductions and future unrealized synergies subject to certain limits and conditions as specified in the 2018 Coty Credit Agreement, as amended.
Schedule of line of credit facilities	Fair Value of Debt December 31, 2024 June 30, 2024 Carrying Fair Carrying Fair Senior Secured Notes $ 3,369.3 $ 3,396.1 $ 3,716.7 $ 3,719.7 2018 Coty Credit Agreement 80.0 80.0 — — Senior Unsecured Notes — — 192.7 192.8
Schedule of maturities of long-term debt	Aggregate maturities of the Company’s long-term debt, including the current portion of long-term debt and excluding short-term debt and finance lease obligations as of December 31, 2024, are presented below: Fiscal Year Ending June 30, 2025, remaining $ 10.0 2026 1,078.5 2027 520.4 2028 — 2029 1,090.4 Thereafter 750.0 Total $ 3,449.3

INTEREST EXPENSE, NET (Tables)

INTEREST EXPENSE, NET (Tables)	6 Months Ended
	Dec. 31, 2024
Interest Income (Expense), Operating [Abstract]
Schedule of interest expense, net	Interest expense, net for the three and six months ended December 31, 2024 and 2023, respectively, is presented below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Interest expense $ 56.7 $ 61.7 $ 117.1 $ 128.5 Foreign exchange losses, net of derivative contracts 1.4 2.3 6.1 10.5 Interest income (3.7) (3.9) (7.0) (9.1) Total interest expense, net $ 54.4 $ 60.1 $ 116.2 $ 129.9

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	6 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of net benefit costs	The components of net periodic benefit cost for pension plans and other post-employment benefit plans recognized in the Condensed Consolidated Statements of Operations are presented below: Three Months Ended December 31, Pension Plans Other Post- U.S. International Total 2024 2023 2024 2023 2024 2023 2024 2023 Service cost — — 1.3 1.3 0.1 0.1 1.4 1.4 Interest cost 0.2 0.2 3.0 3.2 0.4 0.4 3.6 3.8 Expected return on plan assets — — (1.3) (1.2) — — (1.3) (1.2) Amortization of prior service credit — — — — — (0.1) — (0.1) Amortization of net (gain) loss — (0.2) (0.3) (0.6) (0.7) (0.6) (1.0) (1.4) Net periodic benefit cost (credit) 0.2 — 2.7 2.7 (0.2) (0.2) 2.7 2.5 Six Months Ended December 31, Pension Plans Other Post- U.S. International Total 2024 2023 2024 2023 2024 2023 2024 2023 Service cost — — 2.6 2.6 0.2 0.2 2.8 2.8 Interest cost 0.4 0.4 6.0 6.4 0.8 0.8 7.2 7.6 Expected return on plan assets — — (2.6) (2.4) — — (2.6) (2.4) Amortization of prior service credit — — — — — (0.2) — (0.2) Amortization of net (gain) loss — (0.4) (0.6) (1.2) (1.4) (1.2) (2.0) (2.8) Net periodic benefit cost (credit) 0.4 — 5.4 5.4 (0.4) (0.4) 5.4 5.0

DERIVATIVE INSTRUMENTS (Tables)

DERIVATIVE INSTRUMENTS (Tables)	6 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of amount of gains and losses recognized in other comprehensive income (loss)	The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended Six Months Ended 2024 2023 2024 2023 Foreign exchange forward contracts $ 1.7 $ (1.1) $ 1.1 $ — Interest rate swap contracts — (1.1) — (0.1) Net investment hedges 105.8 (27.6) 45.6 (9.9)
Schedule of amount of gains and losses recognized in other comprehensive income (loss)	The amount of gains and losses recognized in Other comprehensive income (loss) (“OCI”) in the Condensed Consolidated Balance Sheets related to the Company’s derivative and non-derivative financial instruments which are designated as hedging instruments is presented below: Gain (Loss) Recognized in OCI Three Months Ended Six Months Ended 2024 2023 2024 2023 Foreign exchange forward contracts $ 1.7 $ (1.1) $ 1.1 $ — Interest rate swap contracts — (1.1) — (0.1) Net investment hedges 105.8 (27.6) 45.6 (9.9)
Schedule of amount of gains and losses reclassified from AOCI(L)	The amount of gains and losses reclassified from AOCI/(L) to the Condensed Consolidated Statements of Operations related to the Company’s derivative financial instruments which are designated as hedging instruments is presented below: Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Three Months Ended December 31, 2024 2023 Cost of sales Interest expense, net Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ 0.7 $ — $ (1.4) $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — 0.4 — 0.6 Location and Amount of Gain (Loss) Recognized in Income on Cash Flow Hedging Relationships Six Months Ended December 31, 2024 2023 Cost of sales Interest expense, net Cost of sales Interest expense, net Foreign exchange forward contracts: Amount of gain (loss) reclassified from AOCI into income $ 0.9 $ — $ (2.1) $ — Interest rate swap contracts: Amount of gain (loss) reclassified from AOCI into income — 0.8 — 1.2
Schedule of derivatives not designated as hedging	The amount of gains and losses related to the Company’s derivative financial instruments not designated as hedging instruments is presented below: Condensed Consolidated Statements of Operations Three Months Ended Six Months Ended 2024 2023 2024 2023 Foreign exchange contracts Selling, general and administrative expenses $ 0.3 $ (0.2) $ 0.4 $ (0.1) Foreign exchange contracts (a) Interest expense, net (50.4) 32.1 (22.8) 2.7 Foreign exchange and forward repurchase contracts Other income (expense), net (126.0) 72.1 (168.1) (3.6) (a) The losses and gains for these foreign exchange contracts were offset against the gains and losses from revaluation of debt denominated in foreign currency included in Interest expense, net .

EQUITY AND CONVERTIBLE PREFER_2

EQUITY AND CONVERTIBLE PREFERRED STOCK (Tables)	6 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of accumulated other comprehensive income (loss)	Accumulated Other Comprehensive Income (Loss) Foreign Currency Translation Adjustments Gain on Cash Flow Hedges (Loss) gain on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans (a) Total Balance—July 1, 2024 $ 2.1 $ (23.0) $ (823.0) $ 48.8 $ (795.1) Other comprehensive income (loss) before reclassifications 0.7 45.6 (206.7) (1.2) (161.6) Net amounts reclassified from AOCI/(L) (1.2) — — (1.1) (2.3) Net current-period other comprehensive (loss) income (0.5) 45.6 (206.7) (2.3) (163.9) Balance—December 31, 2024 $ 1.6 $ 22.6 $ (1,029.7) $ 46.5 $ (959.0) (a) For the six months ended December 31, 2024, other comprehensive loss before reclassifications of $1.2 and net amounts reclassified from AOCI/(L) related to pensions and other post-employment benefit plans included amortization of prior service credits and actuarial losses of $2.0, net of tax of $0.9. Foreign Currency Translation Adjustments Loss on Cash Flow Hedges Loss on Net Investment Hedge Other Foreign Currency Translation Adjustments Pension and Other Post-Employment Benefit Plans Total Balance—July 1, 2023 $ 0.7 $ (49.8) $ (667.9) $ 54.6 $ (662.4) Other comprehensive (loss) income before reclassifications (0.1) (9.9) 66.8 1.0 57.8 Net amounts reclassified from AOCI/(L) 0.5 — — (2.5) (2.0) Net current-period other comprehensive income (loss) 0.4 (9.9) 66.8 (1.5) 55.8 Balance—December 31, 2023 $ 1.1 $ (59.7) $ (601.1) $ 53.1 $ (606.6)

SHARE-BASED COMPENSATION PLANS

SHARE-BASED COMPENSATION PLANS (Tables)	6 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of share-based compensation expense	Share-based compensation expense is recognized on a straight-line basis over the requisite service period. Total share-based compensation is shown in the table below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Equity plan expense (a) $ 15.2 $ 19.9 $ 32.1 $ 50.1 Liability plan (income) expense 0.3 0.3 0.4 (0.2) Fringe expense 2.9 3.1 2.9 3.1 Total share-based compensation expense $ 18.4 $ 23.3 $ 35.4 $ 53.0 (a) Equity plan share-based compensation expense was recorded to additional paid in capital and presented in the Condensed Consolidated Statements of Equity.

NET INCOME ATTRIBUTABLE TO CO_2

NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE (Tables)	6 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of reconciliation of numerators and denominators of basic and diluted EPS computations	Reconciliation between the numerators and denominators of the basic and diluted income per share (“EPS”) computations is presented below: Three Months Ended Six Months Ended 2024 2023 2024 2023 Amounts attributable to Coty Inc.: Net income attributable to Coty Inc. $ 23.7 $ 180.9 $ 106.6 $ 182.5 Convertible Series B Preferred Stock dividends (3.3) (3.3) (6.6) (6.6) Net income (loss) attributable to common stockholders $ 20.4 $ 177.6 $ 100.0 $ 175.9 Weighted-average common shares outstanding: Weighted-average common shares outstanding—Basic 871.4 892.8 869.6 873.6 Effect of dilutive stock options and Series A Preferred Stock (a) — — — 0.1 Effect of restricted stock and RSUs (b) 3.8 6.3 5.6 9.6 Effect of Convertible Series B Preferred Stock (c) — 23.7 — — Effect of Forward Repurchase Contracts (d) — — — — Weighted-average common shares outstanding—Diluted 875.2 922.8 875.2 883.3 Earnings per common share: Earnings per common share - basic $ 0.02 $ 0.20 $ 0.11 $ 0.20 Earnings per common share - diluted (e) 0.02 0.20 0.11 0.20 (a) For the three months ended December 31, 2024 and 2023, outstanding stock options with rights to purchase 3.5 million and 3.9 million shares of Common Stock were anti-dilutive and excluded from the computation of diluted EPS. Series A Preferred Stock had no dilutive effect, as the exchange right expired on March 27, 2024. For the six months ended December 31, 2024 and 2023, outstanding stock options and Series A Preferred Stock with purchase or conversion rights to purchase 3.5 million and 2.9 million weighted average shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. (b) For the three months ended December 31, 2024 and 2023, there were 13.7 million and 3.9 million anti-dilutive RSUs, respectively, excluded from the computation of Diluted EPS. For the three months ended December 31, 2024 and 2023, there were no restricted stock outstanding. For the six months ended December 31, 2024 and 2023, there were 6.8 million and 2.0 million weighted average anti-dilutive RSUs, respectively, excluded from the computation of diluted EPS. (c) For the three and six months ended December 31, 2024, no dilutive shares of Convertible Series B Preferred Stock were included in the computation of diluted EPS as their inclusion would be anti-dilutive. For the three months ended December 31, 2023, there were 23.7 million dilutive shares of Convertible Series B Preferred Stock included in the computation of diluted EPS as their inclusion would be dilutive. For the six months ended December 31, 2023, no dilutive shares of Convertible Series B Preferred Stock were included in the computation of diluted EPS as their inclusion would be anti-dilutive. (d) For the three and six months ended December 31, 2024 and 2023, no dilutive shares of the Forward Repurchase Contracts were included in the computation of diluted EPS as their inclusion would be anti-dilutive. (e) Diluted EPS is adjusted by the effect of dilutive securities, including awards under the Company's equity compensation plans, the convertible Series B Preferred Stock, and the Forward Repurchase Contracts. When calculating any potential dilutive effect of stock options, Series A Preferred Stock, restricted stock, RSUs and PRSUs, the Company uses the treasury method and the if-converted method for the Convertible Series B Preferred Stock and the Forward Repurchase Contracts. The treasury method typically does not adjust the net income attributable to Coty Inc., while the if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $3.3, and to reverse the impact of fair market value losses/(gains) for contracts with the option to settle in shares or cash of $96.5 and $(44.4), respectively, if dilutive, for the three months ended December 31, 2024 and 2023 on net income applicable to common stockholders during the period. The if-converted method requires an adjustment to reverse the impact of the preferred stock dividends of $6.6, and to reverse the impact of fair market value losses/(gains) for contracts with the option to settle in shares or cash of $128.8 and $(0.2) respectively, if dilutive, for the six months ended December 31, 2024 and 2023 on net income applicable to common stockholders during the period.

COMMITMENT AND CONTINGENCIES (T

COMMITMENT AND CONTINGENCIES (Tables)	6 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of income tax contingencies	The Company’s Brazilian subsidiaries receive tax assessments from local, state and federal tax authorities in Brazil from time to time. Current open tax assessments as of December 31, 2024 are: Assessment received Type of assessment Type of Tax Tax period impacted Estimated amount, including interest and penalties as of December 31, 2024 Aug-20 State sales tax credits, which the Treasury Office of the State of Goiás considers as improperly registered ICMS 2017-2019 R$684.0 million (approximately $110.7) Oct-20 Federal excise taxes, which the Treasury Office of the Brazil’s Internal Revenue Service considers as improperly calculated IPI 2016-2017 R$454.0 million (approximately $73.5) Nov-22 IPI 2018-2019 R$616.2 million (approximately $99.7) Mar-24 IPI 2020 R$34.8 million (approximately $5.6) Nov-20 State sales taxes, which the Treasury Office of the State of Minas Gerais considers as improperly calculated ICMS 2016-2019 R$234.6 million (approximately $38.0) Jun-21 State sales tax, which the Treasury Office of the State of Goiás considers as improperly calculated ICMS 2016-2020 R$55.0 million (approximately $8.9)

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Accounting Policies [Abstract]
Restricted cash	$ 19		$ 19		$ 19.8
Effective income tax rate, percentage	45.90%	27.70%	35.90%	36.40%
Change in enacted tax rate, amount				$ 24.3
Gross unrecognized tax benefits	$ 212.5		$ 212.5		215.3
Unrecognized tax benefits that would impact effective tax rate	178.7		178.7
Unrecognized tax benefits, net	213.9		213.9		200.2
Interest and penalties expense	0.8	$ 0.7	4.6	$ 2
Gross accrued interest and penalties	34.8		34.8		$ 30.2
Reasonably possible decrease in UTBs (up to)	$ 29.6		$ 29.6

SEGMENT REPORTING - Schedule of

SEGMENT REPORTING - Schedule of reportable segments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net revenues	$ 1,669.9	$ 1,727.6	$ 3,341.4	$ 3,369
Operating income (loss)	268.2	236.7	506	434.2
Interest expense, net	54.4	60.1	116.2	129.9
Other expense (income), net	157.2	(80.8)	200.5	(4.2)
Income before income taxes	56.6	257.4	189.3	308.5
Operating Segments | Prestige
Segment Reporting Information [Line Items]
Net revenues	1,116.1	1,122.6	2,230.2	2,187.3
Operating income (loss)	222.3	200.6	463.8	422.2
Operating Segments | Consumer Beauty
Segment Reporting Information [Line Items]
Net revenues	553.8	605	1,111.2	1,181.7
Operating income (loss)	64.1	60.4	78.1	92.4
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Operating income (loss)	$ (18.2)	$ (24.3)	$ (35.9)	$ (80.4)

SEGMENT REPORTING - Schedule _2

SEGMENT REPORTING - Schedule of percentage of revenues associated with product categories (Details) - Product Concentration Risk - Sales Revenue	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	100%	100%	100%	100%
Fragrance
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	70.60%	67.30%	70.40%	66.90%
Color Cosmetics
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	22.30%	24.10%	22.20%	24.30%
Body Care & Other
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	4.40%	5.70%	4.50%	5.70%
Skincare
Segment Reporting Information [Line Items]
Percentage of consolidated revenues	2.70%	2.90%	2.90%	3.10%

RESTRUCTURING COSTS - Schedule

RESTRUCTURING COSTS - Schedule of restructuring costs (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Total Restructuring Actions	$ 1.4	$ 5.7	$ 2.1	$ 34.1

RESTRUCTURING COSTS - Narrative

RESTRUCTURING COSTS - Narrative (Details) - Current Restructuring Actions - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2027	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2024	Jun. 30, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring reserve				$ 39.9	$ 42.6
Forecast
Restructuring Cost and Reserve [Line Items]
Payments for restructuring	$ 6.8	$ 19.3	$ 13.8

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Inventory Disclosure [Abstract]
Raw materials	$ 197.4	$ 201.2
Work-in-process	11	10.4
Finished goods	497.4	552.5
Total inventories	$ 705.8	$ 764.1

EQUITY INVESTMENTS - Schedule o

EQUITY INVESTMENTS - Schedule of equity investments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024	Jan. 04, 2021
Debt and Equity Securities, FV-NI [Line Items]
Total equity investments	$ 1,056.7		$ 1,056.7		$ 1,090.6
KKW Beauty
Debt and Equity Securities, FV-NI [Line Items]
Percentage of equity interests acquired						20%
KKW Beauty
Debt and Equity Securities, FV-NI [Line Items]
Equity method investments	3.7		3.7		5.6
Net loss in other expense (income), net	0.9	$ 0.9	1.9	$ 1.7
Wella Company
Debt and Equity Securities, FV-NI [Line Items]
Equity investments at fair value	$ 1,053		$ 1,053		$ 1,085
Ownership percentage	25.84%		25.84%		25.84%

EQUITY INVESTMENTS - Schedule_2

EQUITY INVESTMENTS - Schedule of movement in equity investments (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Debt and Equity Securities, FV-NI [Line Items]
Net revenues	$ 1,669.9	$ 1,727.6	$ 3,341.4	$ 3,369
Gross profit	1,114.2	1,124.1	2,208.8	2,166
Operating income	268.2	236.7	506	434.2
Income before income taxes	56.6	257.4	189.3	308.5
Net income (loss)	30.6	186	121.3	196.2
KKW Beauty And Wella
Debt and Equity Securities, FV-NI [Line Items]
Gross profit	507.4	472.1	953.1	898.9
Net income (loss)	19.2	74.2	(6.9)	57.5
KKW Beauty And Wella
Debt and Equity Securities, FV-NI [Line Items]
Net revenues	737.9	703.9	1,393.4	1,341.2
Operating income	109.1	79.6	147.8	124.5
Income before income taxes	$ 51.3	$ 24.2	$ 48.8	$ 17.4

EQUITY INVESTMENTS - Schedule_3

EQUITY INVESTMENTS - Schedule of movement in equity investments (Details) - Wella Company $ in Millions	6 Months Ended
	Dec. 31, 2024 USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance as of June 30, 2024	$ 1,085
Total losses included in earnings	(32)
Balance as of December 31, 2024	$ 1,053

EQUITY INVESTMENTS - Schedule_4

EQUITY INVESTMENTS - Schedule of significant unobservable inputs used in Level 3 valuation (Details) - Wella Company $ in Millions	Dec. 31, 2024 USD ($)	Jun. 30, 2024 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 1,053	$ 1,085
Fair Value, Inputs, Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value	$ 1,053
Fair Value, Inputs, Level 3 | Discounted cash flows | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	0.0950
Fair Value, Inputs, Level 3 | Discounted cash flows | Growth rate | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	0.020
Fair Value, Inputs, Level 3 | Discounted cash flows | Growth rate | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	0.071
Fair Value, Inputs, Level 3 | Market multiple | Revenue multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	1.8
Fair Value, Inputs, Level 3 | Market multiple | Revenue multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	2
Fair Value, Inputs, Level 3 | Market multiple | EBITDA multiple | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	10.1
Fair Value, Inputs, Level 3 | Market multiple | EBITDA multiple | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Range	11.9

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of goodwill (Details) $ in Millions	6 Months Ended
	Dec. 31, 2024 USD ($)
Goodwill [Roll Forward]
Gross beginning balance	$ 7,945.8
Accumulated impairments beginning balance	(4,040.1)
Net beginning balance	3,905.7
Foreign currency translation	(89.3)
Gross ending balance	7,856.5
Accumulated impairments ending balance	(4,040.1)
Net ending balance	3,816.4
Prestige
Goodwill [Roll Forward]
Gross beginning balance	6,214.6
Accumulated impairments beginning balance	(3,110.3)
Net beginning balance	3,104.3
Foreign currency translation	(70.5)
Gross ending balance	6,144.1
Accumulated impairments ending balance	(3,110.3)
Net ending balance	3,033.8
Consumer Beauty
Goodwill [Roll Forward]
Gross beginning balance	1,731.2
Accumulated impairments beginning balance	(929.8)
Net beginning balance	801.4
Foreign currency translation	(18.8)
Gross ending balance	1,712.4
Accumulated impairments ending balance	(929.8)
Net ending balance	$ 782.6

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of other intangible assets, net (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Indefinite-lived other intangible assets	$ 935	$ 944.6
Finite-lived other intangible assets, net	2,483.4	2,621
Total Other intangible assets, net	$ 3,418.4	$ 3,565.6

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of indefinite lived intangible assets (Details) $ in Millions	6 Months Ended
	Dec. 31, 2024 USD ($)
Indefinite-lived Intangible Assets [Roll Forward]
Gross beginning balance	$ 1,889.5
Accumulated impairments beginning balance	(944.9)
Net beginning balance	944.6
Foreign currency translation	(9.6)
Gross ending balance	1,879.9
Accumulated impairments ending balance	(944.9)
Net ending balance	935
Trademarks
Indefinite-lived Intangible Assets [Roll Forward]
Gross beginning balance	1,889.5
Accumulated impairments beginning balance	(944.9)
Net beginning balance	944.6
Foreign currency translation	(9.6)
Gross ending balance	1,879.9
Accumulated impairments ending balance	(944.9)
Net ending balance	$ 935

GOODWILL AND OTHER INTANGIBLE_6

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Schedule of intangible assets subject to amortization (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Finite-Lived Intangible Assets [Line Items]
Cost	$ 4,778.8	$ 4,852.3
Accumulated Amortization	(2,269.8)	(2,205.7)
Accumulated Impairment	(25.6)	(25.6)
Net	2,483.4	2,621
License agreements and collaboration agreements
Finite-Lived Intangible Assets [Line Items]
Cost	3,656	3,715.1
Accumulated Amortization	(1,476.3)	(1,422.5)
Accumulated Impairment	(19.6)	(19.6)
Net	2,160.1	2,273
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Cost	731.4	741.8
Accumulated Amortization	(534.1)	(527.8)
Accumulated Impairment	(5.5)	(5.5)
Net	191.8	208.5
Trademarks
Finite-Lived Intangible Assets [Line Items]
Cost	309.9	311.7
Accumulated Amortization	(197.5)	(192.4)
Accumulated Impairment	(0.5)	(0.5)
Net	111.9	118.8
Product formulations and technology
Finite-Lived Intangible Assets [Line Items]
Cost	81.5	83.7
Accumulated Amortization	(61.9)	(63)
Accumulated Impairment	0	0
Net	$ 19.6	$ 20.7

GOODWILL AND OTHER INTANGIBLE_7

GOODWILL AND OTHER INTANGIBLE ASSETS, NET - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 47.3	$ 48.3	$ 95.4	$ 96.9

LEASES - Narrative (Details)

LEASES - Narrative (Details)	Dec. 31, 2024
Minimum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, term of contract	4 years
Maximum
Lessee, Lease, Description [Line Items]
Lessee, operating lease, term of contract	25 years

LEASES - Schedule of lease cost

LEASES - Schedule of lease cost (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Lease Cost:
Operating lease cost	$ 19.4	$ 18.7	$ 38.2	$ 37.8
Short-term lease cost	0.7	0.5	1.4	0.8
Variable lease cost	10.7	8.9	22.4	19.6
Sublease income	(3.8)	(4.5)	(7.4)	(8.4)
Net lease cost	27	23.6	54.6	49.8
Other information:
Operating cash outflows from operating leases	(18.1)	(18)	(34.9)	(37.2)
Right-of-use assets obtained in exchange for lease obligations	$ 0.5	$ 17.7	$ 19.1	$ 32.7
Weighted-average remaining lease term - real estate	6 years 6 months	6 years 10 months 24 days	6 years 6 months	6 years 10 months 24 days
Weighted-average discount rate - real estate leases	4.54%	4.42%	4.54%	4.42%

LEASES - Schedule of future min

LEASES - Schedule of future minimum lease payments for operating leases (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Minimum lease payments
2025, remaining	$ 35.3
2026	60.1
2027	52.6
2028	40
2029	34.8
Thereafter	80.3
Total future lease payments	303.1
Less: imputed interest	(43.6)
Total present value of lease liabilities	259.5
Current operating lease liabilities	56.2	$ 57.8
Long-term operating lease liabilities	203.3	$ 218.7
Total operating lease liabilities	$ 259.5

DEBT - Schedule of debt (Detail

DEBT - Schedule of debt (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
Debt Instrument [Line Items]
Short-term debt	$ 1.5	$ 0
Long-term debt	3,449.3
Finance lease obligations & other long term debt	8.2	4.3
Total debt	3,459	3,913.7
Less: Short-term debt and current portion of long-term debt	(14.4)	(3)
Total Long-term debt	3,444.6	3,910.7
Less: Unamortized financing fees and discounts on long-term debt	(57.6)	(68.9)
Total Long-term debt, net	3,387	3,841.8
Senior Secured Notes | 2026 Dollar Senior Secured Notes due April 2026
Debt Instrument [Line Items]
Long-term debt	350	650
Senior Secured Notes | 2026 Euro Senior Secured Notes due April 2026
Debt Instrument [Line Items]
Long-term debt	728.5	748.1
Senior Secured Notes | 2027 Euro Senior Secured Notes due May 2027
Debt Instrument [Line Items]
Long-term debt	520.4	534.3
Senior Secured Notes | 2028 Euro Senior Secured Notes due September 2028
Debt Instrument [Line Items]
Long-term debt	520.4	534.3
Senior Secured Notes | 2029 Dollar Senior Secured Notes due January 2029
Debt Instrument [Line Items]
Long-term debt	500	500
Senior Secured Notes | 2030 Dollar Senior Secured Notes due July 2030
Debt Instrument [Line Items]
Long-term debt	750	750
Line of Credit | Coty Revolving Credit Facility due July 2028 | Revolving Credit Facility
Debt Instrument [Line Items]
Long-term debt	80	0
Current portion of long-term debt includes swingline loans outstanding	10	0
Line of Credit | 2026 Euro Notes due April 2026 | Term Loan
Debt Instrument [Line Items]
Long-term debt	$ 0	$ 192.7

DEBT - Narrative (Details)

DEBT - Narrative (Details)

3 Months Ended

6 Months Ended

Jul. 26, 2023 USD ($)

Jul. 11, 2023 USD ($)

Nov. 30, 2021

Jun. 16, 2021

Apr. 21, 2021

Apr. 05, 2018 USD ($)

Dec. 31, 2024 USD ($) fiscalQuarter

Dec. 31, 2023 USD ($)

Dec. 31, 2024 USD ($) fiscalQuarter

Dec. 31, 2023 USD ($)

Dec. 10, 2024 USD ($)

Dec. 06, 2024 USD ($)

Dec. 06, 2024 EUR (€)

Jun. 30, 2024 USD ($)

May 30, 2024 USD ($)

May 30, 2024 EUR (€)

Dec. 07, 2023 USD ($)

Sep. 19, 2023 EUR (€)

Jul. 11, 2023 EUR (€)

Apr. 05, 2018 EUR (€)

Debt Instrument [Line Items]

Short-term debt

$ 1,500,000

$ 1,500,000

$ 0

Long-term debt

3,449,300,000

3,449,300,000

Debt discount capitalized

0

$ 0

0

$ 40,400,000

Line of Credit

Debt Instrument [Line Items]

Deferred financing fees write-offs

$ 1,600,000

$ 2,200,000

$ 1,600,000

$ 7,400,000

Total net leverage ratio, material acquisition, number of fiscal quarters | fiscalQuarter

4

4

Total net leverage ratio, after material acquisition | fiscalQuarter

2

2

Line of Credit | Maximum

Debt Instrument [Line Items]

Applicable leverage ratio following the closing of any material acquisition

5.95

Line of Credit | Minimum

Debt Instrument [Line Items]

Applicable leverage ratio following the closing of any material acquisition

1

2026 Euro Notes | Senior Unsecured Notes

Debt Instrument [Line Items]

Long-term debt

$ 190,600,000

€ 180,300,000

$ 323,000,000

$ 150,000,000

Debt Instrument, face amount | €

€ 250,000,000

Interest rate, stated percentage

4.75%

4.75%

2026 Dollar Senior Secured Notes | Cash Tender Offers

Debt Instrument [Line Items]

Long-term debt

$ 300,000,000

2030 Dollar Senior Secured Notes, due April 2030 | Senior Unsecured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 750,000,000

Interest rate, stated percentage

6.625%

Proceeds from issuance of senior long-term debt

$ 740,600,000

2028 Euro Senior Secured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount | €

€ 493,800,000

2028 Euro Senior Secured Notes | Senior Unsecured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount | €

€ 500,000,000

Interest rate, stated percentage

5.75%

2027 Euro Senior Secured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount | €

€ 493,700,000

2027 Euro Senior Secured Notes | Senior Unsecured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount | €

€ 500,000,000

Interest rate, stated percentage

4.50%

4.50%

2026 Dollar Senior Secured Notes due April 2026 | Senior Unsecured Notes

Debt Instrument [Line Items]

Long-term debt

$ 350,000,000

$ 350,000,000

650,000,000

Debt instrument, early redemption premium, percent of outstanding principal amount

1%

Debt instrument, base redemption price, percentage

100%

2026 Dollar Senior Secured Notes due April 2026 | Senior Unsecured Notes | Bund Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

0.50%

2026 Euro Senior Secured Notes due April 2026 | Senior Unsecured Notes

Debt Instrument [Line Items]

Long-term debt

728,500,000

728,500,000

748,100,000

Debt instrument, early redemption premium, percent of outstanding principal amount

1%

Debt instrument, base redemption price, percentage

100%

2026 Euro Senior Secured Notes due April 2026 | Senior Unsecured Notes | US Treasury (UST) Interest Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

0.50%

2029 Dollar Senior Secured Notes due January 2029 | Senior Unsecured Notes

Debt Instrument [Line Items]

Long-term debt

500,000,000

500,000,000

500,000,000

Debt instrument, early redemption premium, percent of outstanding principal amount

1%

Debt instrument, base redemption price, percentage

100%

2029 Dollar Senior Secured Notes due January 2029 | Senior Unsecured Notes | US Treasury (UST) Interest Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

0.50%

2030 Dollar Senior Secured Notes due July 2030 | Senior Unsecured Notes

Debt Instrument [Line Items]

Long-term debt

750,000,000

$ 750,000,000

750,000,000

Debt instrument, early redemption premium, percent of outstanding principal amount

1%

Debt instrument, base redemption price, percentage

100%

2030 Dollar Senior Secured Notes due July 2030 | Senior Unsecured Notes | US Treasury (UST) Interest Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

0.50%

2028 Euro Senior Secured Notes due September 2028 | Senior Unsecured Notes

Debt Instrument [Line Items]

Long-term debt

520,400,000

$ 520,400,000

534,300,000

Debt instrument, early redemption premium, percent of outstanding principal amount

1%

Debt instrument, base redemption price, percentage

100%

2028 Euro Senior Secured Notes due September 2028 | Senior Unsecured Notes | US Treasury (UST) Interest Rate

Debt Instrument [Line Items]

Basis spread on variable rate, percentage

0.50%

2018 Coty Term A Facility

Debt Instrument [Line Items]

Aggregate principal amount | €

€ 2,035,000,000

2018 Coty Term A Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

2018 Coty Term B Facility

Debt Instrument [Line Items]

Aggregate principal amount | €

€ 850,000,000

2018 Coty Term B Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

1,400,000,000

2018 Coty Credit Agreement | Line of Credit

Debt Instrument [Line Items]

Credit spread adjustment

0.10%

2018 Coty Credit Agreement | Line of Credit | Refinancing in Dollars and Certain Other Currencies

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,670,000,000

2018 Coty Credit Agreement | Line of Credit | Refinancing in Euros

Debt Instrument [Line Items]

Aggregate principal amount | €

€ 300,000,000

2026 Dollar Notes | Senior Unsecured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount

$ 550,000,000

Interest rate, stated percentage

6.50%

6.50%

2023 Euro Notes | Senior Unsecured Notes

Debt Instrument [Line Items]

Debt Instrument, face amount | €

€ 550,000,000

Interest rate, stated percentage

4%

4%

Letter of Credit

Debt Instrument [Line Items]

Undrawn letters of credit and bank guarantees

4,100,000

$ 4,100,000

4,100,000

Letter of Credit | 2023 Coty Revolving Credit Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

$ 150,000,000

Bank Guarantee

Debt Instrument [Line Items]

Undrawn letters of credit and bank guarantees

$ 18,200,000

$ 18,200,000

$ 18,400,000

Swingline loans | 2023 Coty Revolving Credit Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

150,000,000

Incurrence Incremental Facilities | 2023 Coty Revolving Credit Facility | Line of Credit

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,700,000,000

Net leverage ratio

3

DEBT - Schedule of debt instrum

DEBT - Schedule of debt instrument redemption (Details) - Senior Secured Notes	6 Months Ended
	Dec. 31, 2024
2026 Dollar Senior Secured Notes due April 2026 | 2025
Debt Instrument [Line Items]
Redemption price, percentage	100%
2026 Euro Senior Secured Notes due April 2026 | 2025
Debt Instrument [Line Items]
Redemption price, percentage	100%
2027 Euro Senior Secured Notes due May 2027 | 2026
Debt Instrument [Line Items]
Redemption price, percentage	102.25%
2027 Euro Senior Secured Notes due May 2027 | 2027
Debt Instrument [Line Items]
Redemption price, percentage	100%
2027 Euro Senior Secured Notes due November 2027 | 2026
Debt Instrument [Line Items]
Redemption price, percentage	100%
2028 Euro Senior Secured Notes due September 2028 | 2025
Debt Instrument [Line Items]
Redemption price, percentage	102.875%
2028 Euro Senior Secured Notes due September 2028 | 2026
Debt Instrument [Line Items]
Redemption price, percentage	101.438%
2028 Euro Senior Secured Notes due September 2028 | 2027
Debt Instrument [Line Items]
Redemption price, percentage	100%
2028 Euro Senior Secured Notes due September 2028 | 2028 and thereafter
Debt Instrument [Line Items]
Redemption price, percentage	100%
2029 Dollar Senior Secured Notes due January 2029 | 2025
Debt Instrument [Line Items]
Redemption price, percentage	102.375%
2029 Dollar Senior Secured Notes due January 2029 | 2026
Debt Instrument [Line Items]
Redemption price, percentage	101.188%
2029 Dollar Senior Secured Notes due January 2029 | 2027
Debt Instrument [Line Items]
Redemption price, percentage	100%
2029 Dollar Senior Secured Notes due January 2029 | 2028 and thereafter
Debt Instrument [Line Items]
Redemption price, percentage	100%
2030 Dollar Senior Secured Notes due July 2030 | 2026
Debt Instrument [Line Items]
Redemption price, percentage	103.313%
2030 Dollar Senior Secured Notes due July 2030 | 2027
Debt Instrument [Line Items]
Redemption price, percentage	101.656%
2030 Dollar Senior Secured Notes due July 2030 | 2028 and thereafter
Debt Instrument [Line Items]
Redemption price, percentage	100%

DEBT - Schedule of pricing tier

DEBT - Schedule of pricing tiers (Details)	6 Months Ended
	Dec. 31, 2024
Pricing Tier Five | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	2%
Pricing Tier Five | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1%
Pricing Tier Four | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.75%
Pricing Tier Four | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.75%
Pricing Tier Three | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.50%
Pricing Tier Three | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.50%
Pricing Tier Two | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.25%
Pricing Tier Two | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.25%
Pricing Tier One | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.125%
Pricing Tier One | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.125%
Pricing Tier One | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	2%
Pricing Tier One | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1%
Pricing Tier Two | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.75%
Pricing Tier Two | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.75%
Pricing Tier Three | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.50%
Pricing Tier Three | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.50%
Pricing Tier Four | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.25%
Pricing Tier Four | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.25%
Pricing Tier Five | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1.125%
Pricing Tier Five | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0.125%
Pricing Tier Six | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	1%
Pricing Tier Six | Alternative Base Rate
Debt Instrument [Line Items]
Basis spread on variable rate, percentage	0%
Minimum | Pricing Tier One
Debt Instrument [Line Items]
Net leverage ratio	4.75
Minimum | Pricing Tier Two
Debt Instrument [Line Items]
Net leverage ratio	4
Minimum | Pricing Tier Three
Debt Instrument [Line Items]
Net leverage ratio	2.75
Minimum | Pricing Tier Four
Debt Instrument [Line Items]
Net leverage ratio	2
Minimum | Pricing Tier Five
Debt Instrument [Line Items]
Net leverage ratio	1.50
Maximum | Pricing Tier Two
Debt Instrument [Line Items]
Net leverage ratio	4.75
Maximum | Pricing Tier Three
Debt Instrument [Line Items]
Net leverage ratio	4
Maximum | Pricing Tier Four
Debt Instrument [Line Items]
Net leverage ratio	2.75
Maximum | Pricing Tier Five
Debt Instrument [Line Items]
Net leverage ratio	2
Maximum | Pricing Tier Six
Debt Instrument [Line Items]
Net leverage ratio	1.50

DEBT - Schedule of fair value o

DEBT - Schedule of fair value of debt (Details) - USD ($) $ in Millions	Dec. 31, 2024	Jun. 30, 2024
2018 Coty Credit Agreement | Carrying Amount
Debt Instrument [Line Items]
Fair value of debt	$ 80	$ 0
2018 Coty Credit Agreement | Fair Value
Debt Instrument [Line Items]
Fair value of debt	80	0
Senior Secured Notes | Carrying Amount
Debt Instrument [Line Items]
Fair value of debt	3,369.3	3,716.7
Senior Secured Notes | Fair Value
Debt Instrument [Line Items]
Fair value of debt	3,396.1	3,719.7
Senior Unsecured Notes | Carrying Amount
Debt Instrument [Line Items]
Fair value of debt	0	192.7
Senior Unsecured Notes | Fair Value
Debt Instrument [Line Items]
Fair value of debt	$ 0	$ 192.8

DEBT - Schedule of maturities o

DEBT - Schedule of maturities of long-term debt (Details) $ in Millions	Dec. 31, 2024 USD ($)
Debt Disclosure [Abstract]
2025, remaining	$ 10
2026	1,078.5
2027	520.4
2028	0
2029	1,090.4
Thereafter	750
Total	$ 3,449.3

DEBT - Schedule of total net le

DEBT - Schedule of total net leverage ratio (Details)	6 Months Ended
	Dec. 31, 2024
December 31, 2024 through July 11, 2028
Debt Instrument [Line Items]
Net leverage ratio	4

INTEREST EXPENSE, NET - Schedul

INTEREST EXPENSE, NET - Schedule of interest expense, net (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Interest Income (Expense), Operating [Abstract]
Interest expense	$ 56.7	$ 61.7	$ 117.1	$ 128.5
Foreign exchange losses, net of derivative contracts	1.4	2.3	6.1	10.5
Interest income	(3.7)	(3.9)	(7)	(9.1)
Total interest expense, net	$ 54.4	$ 60.1	$ 116.2	$ 129.9

EMPLOYEE BENEFIT PLANS - Schedu

EMPLOYEE BENEFIT PLANS - Schedule of Components of Net Periodic Benefit Cost (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1.4	$ 1.4	$ 2.8	$ 2.8
Interest cost	3.6	3.8	7.2	7.6
Expected return on plan assets	(1.3)	(1.2)	(2.6)	(2.4)
Amortization of prior service credit	0	(0.1)	0	(0.2)
Amortization of net (gain) loss	(1)	(1.4)	(2)	(2.8)
Net periodic benefit cost (credit)	2.7	2.5	5.4	5
Other Post- Employment Benefits
Defined Benefit Plan Disclosure [Line Items]
Service cost	0.1	0.1	0.2	0.2
Interest cost	0.4	0.4	0.8	0.8
Expected return on plan assets	0	0	0	0
Amortization of prior service credit	0	(0.1)	0	(0.2)
Amortization of net (gain) loss	(0.7)	(0.6)	(1.4)	(1.2)
Net periodic benefit cost (credit)	(0.2)	(0.2)	(0.4)	(0.4)
U.S. | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	0	0	0	0
Interest cost	0.2	0.2	0.4	0.4
Expected return on plan assets	0	0	0	0
Amortization of prior service credit	0	0	0	0
Amortization of net (gain) loss	0	(0.2)	0	(0.4)
Net periodic benefit cost (credit)	0.2	0	0.4	0
International | Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Service cost	1.3	1.3	2.6	2.6
Interest cost	3	3.2	6	6.4
Expected return on plan assets	(1.3)	(1.2)	(2.6)	(2.4)
Amortization of prior service credit	0	0	0	0
Amortization of net (gain) loss	(0.3)	(0.6)	(0.6)	(1.2)
Net periodic benefit cost (credit)	$ 2.7	$ 2.7	$ 5.4	$ 5.4

DERIVATIVE INSTRUMENTS - Narrat

DERIVATIVE INSTRUMENTS - Narrative (Details) € in Millions, $ in Millions	1 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Sep. 30, 2020 USD ($)	Dec. 31, 2024 EUR (€)	Jun. 30, 2024 USD ($)	Jun. 30, 2024 EUR (€)	Nov. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Authorized repurchase amount							$ 294	$ 196
Derivative, forward repurchase contracts term	1 year
Accumulated other comprehensive income (loss)	$ (959)				$ (795.1)
Net investment hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Foreign exchange risk exposure amount (in Euros) | €				€ 2,249.2		€ 1,611.6
Net investment hedge | Other Foreign Currency Translation Adjustments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Accumulated other comprehensive income (loss)	60.2				14.6
Foreign exchange forward contracts
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash flow hedges in AOCI/(L), net of tax	1.6				2.1
Cash flow hedge to be reclassified during next 12 months	1.6
Foreign exchange forward contracts | Net investment hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	20.9				22.3
Foreign exchange forward contracts | Net investment hedge | Other Foreign Currency Translation Adjustments
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Accumulated other comprehensive income (loss)	(37.6)				(37.6)
Cross-currency swap contracts | Net investment hedge
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount	$ 1,223.7				$ 1,797.6
Notional amount terminated			$ 550
Payment for termination of derivative			$ 37.6
Interest rate swap contracts | Interest Rate Risk
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Notional amount		$ 200
Cash receipt from interest rate swap contracts		$ 2.1

DERIVATIVE INSTRUMENTS - Schedu

DERIVATIVE INSTRUMENTS - Schedule of amount of gains and losses recognized in other comprehensive income (loss) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Net investment hedges	$ 105.8	$ (27.6)	$ 45.6	$ (9.9)
Foreign exchange forward contracts
Derivative [Line Items]
Gain (Loss) Recognized in OCI	1.7	(1.1)	1.1	0
Interest rate swap contracts
Derivative [Line Items]
Gain (Loss) Recognized in OCI	$ 0	$ (1.1)	$ 0	$ (0.1)

DERIVATIVE INSTRUMENTS - Sche_2

DERIVATIVE INSTRUMENTS - Schedule of amount of gains and losses reclassified from AOCI(L) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Cost of sales | Foreign exchange forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	$ 0.7	$ (1.4)	$ 0.9	$ (2.1)
Cost of sales | Interest rate swap contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	0	0	0	0
Interest expense, net | Foreign exchange forward contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	0	0	0	0
Interest expense, net | Interest rate swap contracts
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Amount of gain (loss) reclassified from AOCI into income	$ 0.4	$ 0.6	$ 0.8	$ 1.2

DERIVATIVE INSTRUMENTS - Sche_3

DERIVATIVE INSTRUMENTS - Schedule of derivatives not designated as hedging (Details) - Foreign exchange forward contracts - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Selling, general and administrative expenses
Derivative [Line Items]
Gain (loss) recognized in operations	$ 0.3	$ (0.2)	$ 0.4	$ (0.1)
Interest expense, net
Derivative [Line Items]
Gain (loss) recognized in operations	(50.4)	32.1	(22.8)	2.7
Other income (expense), net
Derivative [Line Items]
Gain (loss) recognized in operations	$ (126)	$ 72.1	$ (168.1)	$ (3.6)

EQUITY AND CONVERTIBLE PREFER_3

EQUITY AND CONVERTIBLE PREFERRED STOCK - Narrative (Details)				1 Months Ended			3 Months Ended		6 Months Ended		12 Months Ended
	Oct. 02, 2023 USD ($) $ / shares shares	Sep. 18, 2023 shares	Oct. 29, 2021 shares	Dec. 31, 2024 USD ($) class_of_stock vote $ / shares shares	Nov. 30, 2024 USD ($)	Oct. 31, 2024 USD ($)	Dec. 31, 2024 USD ($) class_of_stock vote $ / shares shares	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($) class_of_stock vote $ / shares shares	Dec. 31, 2023 USD ($)	Jun. 30, 2020 $ / shares shares	Jun. 30, 2024 USD ($) $ / shares shares	Nov. 30, 2023 USD ($)	Nov. 13, 2023 USD ($)	Oct. 02, 2023 € / shares	Dec. 31, 2022 USD ($)	Aug. 27, 2021 shares	Mar. 27, 2017 $ / shares shares	Feb. 03, 2016 USD ($)
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.01			$ 0.01			$ 0.01		$ 0.01			$ 0.01
Common stock, shares authorized (in shares) | shares				1,250,000,000			1,250,000,000		1,250,000,000			1,250,000,000
Common stock, shares outstanding (in shares) | shares				872,000,000			872,000,000		872,000,000			867,800,000
Issuance of common stock in connection with global offering, net of offering costs (in shares) | shares	33,000,000
Shares issued (in dollars per share) | (per share)	$ 10.80														€ 10.28
Deferred offering costs	$ 348,400,000
Underwriting fees	10,000,000
Professional fees	$ 6,000,000
Preferred stock, shares authorized (in shares) | shares				20,000,000			20,000,000		20,000,000			20,000,000
Number of classes of preferred stock | class_of_stock				1			1		1
Preferred stock, par value (in dollars per share) | $ / shares				$ 0.01			$ 0.01		$ 0.01			$ 0.01
Preferred stock, shares issued (in shares) | shares				1,000,000			1,000,000		1,000,000			1,000,000
Preferred stock, shares outstanding (in shares) | shares				1,000,000			1,000,000		1,000,000			1,000,000
Employee taxes									$ 0	$ 100,000
Authorized repurchase amount													$ 294,000,000			$ 196,000,000
Derivative, forward repurchase contracts term				1 year
Weighted average interest rate spread													7.90%			9.50%
Dividends									0
Additional Paid-in Capital
Class of Stock [Line Items]
Dividends payable				$ 0			$ 0	$ 0	0	0
December 2022 Forward Contracts
Class of Stock [Line Items]
Authorized repurchase amount																$ 196,000,000
November 2023 Forward Contracts
Class of Stock [Line Items]
Authorized repurchase amount													$ 294,000,000
Share Repurchase Program
Class of Stock [Line Items]
Additional amount authorized to be repurchased														$ 600,000,000
RSUs
Class of Stock [Line Items]
Preferred stock dividends declared and paid during the period									100,000	300,000
Restricted Stock Units and Phantom Units | Accrued Expenses and Other Current Liabilities
Class of Stock [Line Items]
Dividends payable				$ 800,000			$ 800,000		$ 800,000			$ 800,000
CEO | RSUs | JAB Beauty B.V
Class of Stock [Line Items]
Shares contributed by related party (in shares) | shares		5,000,000	10,000,000
Common Class A
Class of Stock [Line Items]
Common stock, par value (in dollars per share) | $ / shares				$ 0.01			$ 0.01		$ 0.01
Votes per share | vote				1			1		1
Common stock, shares authorized (in shares) | shares				1,250,000,000			1,250,000,000		1,250,000,000
Common stock, shares outstanding (in shares) | shares				872,000,000			872,000,000		872,000,000
Cash payments to counterparties					$ 61,800,000	$ 61,800,000
Common Class A | Incremental Repurchase Program
Class of Stock [Line Items]
Authorized repurchase amount																			$ 500,000,000
Common Class A | Share Repurchase Program
Class of Stock [Line Items]
Share repurchase program, remaining authorized repurchase amount				$ 796,800,000			$ 796,800,000		$ 796,800,000
Common Class A | JAB Beauty B.V
Class of Stock [Line Items]
Parent ownership percentage				54%			54%		54%
Series A Preferred Stock
Class of Stock [Line Items]
Votes per share | vote				0			0		0
Preferred stock, shares authorized (in shares) | shares				1,000,000			1,000,000		1,000,000
Preferred stock, par value (in dollars per share) | $ / shares				$ 0.01			$ 0.01		$ 0.01
Preferred stock, shares issued (in shares) | shares				1,000,000			1,000,000		1,000,000									1,000,000
Preferred stock, shares outstanding (in shares) | shares				1,000,000			1,000,000		1,000,000
Preferred stock, redemption price (in dollars per share) | $ / shares																		$ 0.01
Series B Preferred Stock
Class of Stock [Line Items]
Preferred stock, par value (in dollars per share) | $ / shares											$ 0.01
Sale of stock, shares authorized (in shares) | shares											1,000,000
Sale of stock, price per share (in dollars per share) | $ / shares											$ 1,000
Preferred stock, dividend rate									9%
Dividends declared							$ 3,300,000	3,300,000	$ 6,600,000	6,600,000
Preferred stock dividends declared and paid during the period							3,300,000	$ 3,300,000	6,600,000	$ 6,600,000
Dividends payable				$ 3,300,000			$ 3,300,000		$ 3,300,000			$ 3,300,000
Series B Preferred Stock | KKR | HFS
Class of Stock [Line Items]
Preferred stock, shares issued (in shares) | shares																	146,057

EQUITY AND CONVERTIBLE PREFER_4

EQUITY AND CONVERTIBLE PREFERRED STOCK - Schedule of accumulated other comprehensive income (loss) (Details) - USD ($) $ in Millions	6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	$ 4,011.7	$ 3,997.4
Other comprehensive (loss) income before reclassifications	(161.6)	57.8
Net amounts reclassified from AOCI/(L)	(2.3)	(2)
Net current-period other comprehensive income (loss)	(163.9)	55.8
Ending balance	3,968.9	4,612.7
Total
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(795.1)	(662.4)
Ending balance	(959)	(606.6)
Gain on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	2.1	0.7
Other comprehensive (loss) income before reclassifications	0.7	(0.1)
Net amounts reclassified from AOCI/(L)	(1.2)	0.5
Net current-period other comprehensive income (loss)	(0.5)	0.4
Ending balance	1.6	1.1
(Loss) gain on Net Investment Hedge
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(23)	(49.8)
Other comprehensive (loss) income before reclassifications	45.6	(9.9)
Net amounts reclassified from AOCI/(L)	0	0
Net current-period other comprehensive income (loss)	45.6	(9.9)
Ending balance	22.6	(59.7)
Other Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	(823)	(667.9)
Other comprehensive (loss) income before reclassifications	(206.7)	66.8
Net amounts reclassified from AOCI/(L)	0	0
Net current-period other comprehensive income (loss)	(206.7)	66.8
Ending balance	(1,029.7)	(601.1)
Pension and Other Post-Employment Benefit Plans
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Balance, beginning of period	48.8	54.6
Other comprehensive (loss) income before reclassifications	(1.2)	1
Net amounts reclassified from AOCI/(L)	(1.1)	(2.5)
Net current-period other comprehensive income (loss)	(2.3)	(1.5)
Ending balance	46.5	$ 53.1
Reclassification from accumulated other comprehensive income (loss), current period, before tax	2
Other comprehensive income (loss), tax	$ 0.9

SHARE-BASED COMPENSATION PLAN_2

SHARE-BASED COMPENSATION PLANS - Schedule of share-based compensation (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	$ 18.4	$ 23.3	$ 35.4	$ 53
Equity plan expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	15.2	19.9	32.1	50.1
Liability plan (income) expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	0.3	0.3	0.4	(0.2)
Fringe expense
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total share-based compensation expense	$ 2.9	$ 3.1	$ 2.9	$ 3.1

SHARE-BASED COMPENSATION PLAN_3

SHARE-BASED COMPENSATION PLANS - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions

3 Months Ended

6 Months Ended

Sep. 28, 2023

Sep. 18, 2023

May 04, 2023

Oct. 29, 2021

Dec. 31, 2024

Dec. 31, 2023

Dec. 31, 2024

Dec. 31, 2023

Jun. 30, 2024

Oct. 02, 2023

Aug. 31, 2023

Aug. 31, 2022

Jun. 30, 2021

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation expense (income)

$ 18.4

$ 23.3

$ 35.4

$ 53

Common stock, par value (in dollars per share)

$ 0.01

$ 0.01

$ 0.01

$ 0.01

Common Class A

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock, par value (in dollars per share)

$ 0.01

$ 0.01

Series A Preferred Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Awards granted (in shares)

0

0

0

0

Share-based compensation expense (income)

$ 0

$ (0.1)

$ 0

$ (0.7)

Share-based Payment Arrangement, Option

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total unrecognized share-based compensation expense

0

$ 0

Weighted-average period for unrecognized share-based compensation

0 years

Restricted Stock Units and Other Share Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total unrecognized share-based compensation expense

$ 130

$ 130

Weighted-average period for unrecognized share-based compensation

2 years 2 months 23 days

Awards granted (in shares)

3,800,000

4,500,000

3,800,000

4,500,000

Share-based compensation expense (income)

$ 17.6

$ 19.3

$ 30.8

$ 48.7

Restricted Stock Units and Other Share Awards | CEO

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation expense (income)

5.2

$ 5.2

10.4

$ 26.2

Performance Restricted Stock Units

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total unrecognized share-based compensation expense

$ 36

$ 36

Weighted-average period for unrecognized share-based compensation

3 years 29 days

Awards granted (in shares)

4,000,000

1,600,000

4,100,000

3,700,000

Share-based compensation expense (income)

$ 0.8

$ 3.2

$ 4.5

$ 3.8

Performance Restricted Stock Units | CEO

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation expense (income)

$ 0.1

$ 1.7

$ 1.9

$ 1.8

Shares to be granted for restricted stock awards (in shares)

2,083,333

10,416,665

Award vesting period

5 years

Performance objectives term

3 years

Performance Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

20%

Performance Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

20%

Performance Restricted Stock Units | CEO | Share-based Payment Arrangement, Tranche One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

20%

Performance Restricted Stock Units | CEO | Share Based Payment Arrangement Tranche Four

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

20%

Performance Restricted Stock Units | CEO | Share Based Payment Arrangement Tranche Five

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

20%

RSUs | CEO

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares to be granted for restricted stock awards (in shares)

10,416,667

RSUs | CEO | Second Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Total unrecognized share-based compensation expense

$ 109.6

Shares to be granted for restricted stock awards (in shares)

10,416,667

Award vesting period

5 years

RSUs | CEO | JAB Beauty B.V

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares contributed by related party (in shares)

5,000,000

10,000,000

RSUs | CEO | Common Class A | Second Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock, par value (in dollars per share)

$ 0.01

RSUs | CEO | Share-based Payment Arrangement, Tranche Three

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares to be granted for restricted stock awards (in shares)

10,000,000

RSUs | CEO | Share-based Payment Arrangement, Tranche Three | Second Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

20%

RSUs | CEO | Share-based Payment Arrangement, Tranche Three | JAB Beauty B.V | First Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares contributed by related party (in shares)

5,000,000

RSUs | CEO | Share-based Payment Arrangement, Tranche Three | Common Class A

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock, par value (in dollars per share)

$ 0.01

RSUs | CEO | Share-based Payment Arrangement, Tranche Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares to be granted for restricted stock awards (in shares)

10,000,000

RSUs | CEO | Share-based Payment Arrangement, Tranche Two | First Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares to be granted for restricted stock awards (in shares)

5

10

RSUs | CEO | Share-based Payment Arrangement, Tranche Two | Second Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

15%

RSUs | CEO | Share-based Payment Arrangement, Tranche Two | Common Class A

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock, par value (in dollars per share)

$ 0.01

RSUs | CEO | Share-based Payment Arrangement, Tranche One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares to be granted for restricted stock awards (in shares)

10,000,000

RSUs | CEO | Share-based Payment Arrangement, Tranche One | Second Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

15%

RSUs | CEO | Share-based Payment Arrangement, Tranche One | JAB Beauty B.V

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares contributed by related party (in shares)

10,000,000

RSUs | CEO | Share-based Payment Arrangement, Tranche One | Common Class A

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Common stock, par value (in dollars per share)

$ 0.01

RSUs | CEO | Share Based Payment Arrangement Tranche Four | Second Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

20%

RSUs | CEO | Share Based Payment Arrangement Tranche Five | Second Restricted Stock Units Award

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting rights percentage

30%

Restricted Stock Units and Performance Restricted Stock Units | CEO

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period

7 years

Restricted Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Awards granted (in shares)

0

300,000

0

300,000

Share-based compensation expense (income)

$ 0

$ 0.6

$ 0

$ 1.1

Non-Qualified Options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based compensation expense (income)

$ 0

$ 0.3

$ 0.1

$ 0.1

Options granted (in shares)

0

0

0

0

NET INCOME ATTRIBUTABLE TO CO_3

NET INCOME ATTRIBUTABLE TO COTY INC. PER COMMON SHARE (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023
Amounts attributable to Coty Inc.:
Net income attributable to Coty Inc.	$ 23.7	$ 180.9	$ 106.6	$ 182.5
Convertible Series B Preferred Stock dividends	(3.3)	(3.3)	(6.6)	(6.6)
Net income attributable to common stockholders	$ 20.4	$ 177.6	$ 100	$ 175.9
Weighted-average common shares outstanding:
Weighted-average common shares outstanding—Basic (in shares)	871.4	892.8	869.6	873.6
Effect of dilutive stock options and Series A Preferred Stock (in shares)	0	0	0	0.1
Effect of restricted stock and RSUs (in shares)	3.8	6.3	5.6	9.6
Effect of Convertible Series B Preferred Stock (in shares)	0	23.7	0	0
Effect of Forward Repurchase Contracts (in shares)	0	0	0	0
Weighted-average common shares outstanding—Diluted (in shares)	875.2	922.8	875.2	883.3
Earnings per common share:
Earnings per common share - basic (in dollars per share)	$ 0.02	$ 0.20	$ 0.11	$ 0.20
Earnings per common share - diluted (in dollars per share)	$ 0.02	$ 0.20	$ 0.11	$ 0.20
Convertible Series B Preferred Stock dividends	$ 3.3	$ 3.3	$ 6.6	$ 6.6
Antidilutive​ fair market value losses (gains)	$ 96.5	$ (44.4)	$ 128.8	$ (0.2)
Stock Options and Series A Preferred Stock
Earnings per common share:
Anti-dilutive shares (in shares)	3.5	3.9	3.5	2.9
Series A Preferred Stock
Earnings per common share:
Anti-dilutive shares (in shares)			0
RSUs
Earnings per common share:
Anti-dilutive shares (in shares)	13.7	3.9	6.8	2
Restricted stock outstanding (in shares)	0	0	0	0
Series B Preferred Stock
Earnings per common share:
Anti-dilutive shares (in shares)	0	23.7	0	0
Forward Contracts
Earnings per common share:
Anti-dilutive shares (in shares)	0	0	0	0

REDEEMABLE NONCONTROLLING INT_2

REDEEMABLE NONCONTROLLING INTERESTS (Details) - USD ($) $ in Millions	Dec. 31, 2024	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023
Redeemable Noncontrolling Interest [Line Items]
Non-cash redeemable noncontrolling interest for business combinations	$ 103.1	$ 98.8	$ 93.6	$ 102.2	$ 98.6	$ 93.5
Middle East Subsidiary
Redeemable Noncontrolling Interest [Line Items]
Ownership percentage by noncontrolling owners	25%

COMMITMENT AND CONTINGENCIES -

COMMITMENT AND CONTINGENCIES - Schedule of income tax contingencies (Details) R$ in Millions, $ in Millions	Dec. 31, 2024 USD ($)	Dec. 31, 2024 BRL (R$)	Jun. 30, 2024 USD ($)
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued	$ 34.8		$ 30.2
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2017-2019
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued	110.7	R$ 684.0
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2016-2019
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued	38	234.6
Brazilian Tax Assessments | Pending Litigation | Foreign State Tax Authority | 2016-2020
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued	8.9	55
Brazilian Tax Assessments | Pending Litigation | Foreign Federal Tax Authority | 2016-2017
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued	73.5	454
Brazilian Tax Assessments | Pending Litigation | Foreign Federal Tax Authority | 2018-2019
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued	99.7	616.2
Brazilian Tax Assessments | Pending Litigation | Foreign Federal Tax Authority | 2020
Loss Contingencies [Line Items]
Unrecognized tax benefits, income tax penalties and interest accrued	$ 5.6	R$ 34.8

COMMITMENT AND CONTINGENCIES _2

COMMITMENT AND CONTINGENCIES - Narrative (Details) R$ in Millions, $ in Millions	6 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2024 BRL (R$)	Dec. 31, 2024 BRL (R$)	Jun. 30, 2024 USD ($)
Loss Contingencies [Line Items]
Penalty payment	$ 34.8			$ 30.2
Brazilian Tax Assessments | Foreign State Tax Authority | Pending Litigation | Surety Bond
Loss Contingencies [Line Items]
Penalty payment	21.9		R$ 135.2
Brazilian Tax Assessments | Foreign State Tax Authority | Pending Litigation | Cash Deposits
Loss Contingencies [Line Items]
Cash deposits	24.7	R$ 152.6
Goiás State Tax ICMS Assessment | Foreign State Tax Authority | Pending Litigation | Surety Bond
Loss Contingencies [Line Items]
Penalty payment	72.2		446.2
Minas Gerais State Tax ICMS Assessment | Foreign State Tax Authority | Pending Litigation | Surety Bond
Loss Contingencies [Line Items]
Penalty payment	$ 50.5		R$ 311.9

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Jun. 30, 2024
Related Party Transaction [Line Items]
Gain on sale	$ (157.2)	$ 80.8	$ (200.5)	$ 4.2
Proceeds from contingent consideration from sale of discontinued business			15.6	0
Accounts receivable, related parties	594.3		594.3		$ 441.6
Accounts payable	1,364.6		1,364.6		1,405.6
Other noncurrent liabilities	336.1		336.1		$ 347.4
Share-based compensation expense (income)	18.4	23.3	35.4	53
Sublease income	3.8	4.5	7.4	8.4
Wella Company
Related Party Transaction [Line Items]
Gain on sale	0.4	0.3	0.7	0.6
Accounts receivable, related parties	26.7		26.7
Accounts payable	0.1		0.1
Share-based compensation expense (income)	0.3	0.6	0.7	1.3
Sublease income	$ 2.2	2	$ 4.3	4.1
Wella Company
Related Party Transaction [Line Items]
Ownership percentage	25.84%		25.84%		25.84%
Related Party Transaction, Other Fees | Wella Company
Related Party Transaction [Line Items]
Gain on sale	$ 3.7	1.9	$ 4.6	8.5
Revenue from related parties	1.6	2.7	3	5
Transition Services Agreement Fees | Wella Company
Related Party Transaction [Line Items]
Revenue from related parties	0.1	$ 0.8	0.1	$ 1.8
Wella Company
Related Party Transaction [Line Items]
Other noncurrent liabilities	$ 33		$ 33